Cover Page
Cover Page - USD ($) shares in Billions, $ in Trillions | 12 Months Ended | ||
Jan. 28, 2024 | Feb. 16, 2024 | Jul. 28, 2023 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Jan. 28, 2024 | ||
Current Fiscal Year End Date | --01-28 | ||
Document Transition Report | false | ||
Entity File Number | 0-23985 | ||
Entity Registrant Name | NVIDIA CORP | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 94-3177549 | ||
Entity Address, Address Line One | 2788 San Tomas Expressway | ||
Entity Address, City or Town | Santa Clara | ||
Entity Address, State or Province | CA | ||
Entity Address, Postal Zip Code | 95051 | ||
City Area Code | 408 | ||
Local Phone Number | 486-2000 | ||
Title of 12(b) Security | Common Stock, $0.001 par value per share | ||
Trading Symbol | NVDA | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Document Financial Statement Error Correction [Flag] | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 1.1 | ||
Entity Common Stock, Shares Outstanding | 2.5 | ||
Documents Incorporated by Reference | Portions of the registrant's Proxy Statement for its 2024 Annual Meeting of Shareholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K are incorporated by reference into Part III, Items 10-14 of this Annual Report on Form 10-K. | ||
Entity Central Index Key | 0001045810 | ||
Document Fiscal Year Focus | 2024 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Audit Information
Audit Information | 12 Months Ended |
Jan. 28, 2024 | |
Audit Information [Abstract] | |
Auditor Firm ID | 238 |
Auditor Name | PricewaterhouseCoopers LLP |
Auditor Location | San Jose, California |
Consolidated Statements of Inco
Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Income Statement [Abstract] | |||
Revenue | $ 60,922 | $ 26,974 | $ 26,914 |
Cost of revenue | 16,621 | 11,618 | 9,439 |
Gross profit | 44,301 | 15,356 | 17,475 |
Operating expenses | |||
Research and development | 8,675 | 7,339 | 5,268 |
Sales, general and administrative | 2,654 | 2,440 | 2,166 |
Acquisition termination cost | 0 | 1,353 | 0 |
Total operating expenses | 11,329 | 11,132 | 7,434 |
Operating income | 32,972 | 4,224 | 10,041 |
Interest income | 866 | 267 | 29 |
Interest expense | (257) | (262) | (236) |
Other, net | 237 | (48) | 107 |
Other income (expense), net | 846 | (43) | (100) |
Income before income tax | 33,818 | 4,181 | 9,941 |
Income tax expense (benefit) | 4,058 | (187) | 189 |
Net income | $ 29,760 | $ 4,368 | $ 9,752 |
Net income per share: | |||
Basic (in USD per share) | $ 12.05 | $ 1.76 | $ 3.91 |
Diluted (in USD per share) | $ 11.93 | $ 1.74 | $ 3.85 |
Weighted average shares used in per share computation: | |||
Basic (in shares) | 2,469 | 2,487 | 2,496 |
Diluted (in shares) | 2,494 | 2,507 | 2,535 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Statement of Comprehensive Income [Abstract] | |||
Net income | $ 29,760 | $ 4,368 | $ 9,752 |
Available-for-sale securities: | |||
Net change in unrealized gain (loss) | 80 | (31) | (16) |
Reclassification adjustments for net realized gain included in net income | 0 | 1 | 0 |
Net change in unrealized gain (loss) | 80 | (30) | (16) |
Cash flow hedges: | |||
Net change in unrealized gain (loss) | 38 | 47 | (43) |
Reclassification adjustments for net realized gain (loss) included in net income | (48) | (49) | 29 |
Net change in unrealized loss | (10) | (2) | (14) |
Other comprehensive income (loss), net of tax | 70 | (32) | (30) |
Total comprehensive income | $ 29,830 | $ 4,336 | $ 9,722 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Millions | Jan. 28, 2024 | Jan. 29, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 7,280 | $ 3,389 |
Marketable securities | 18,704 | 9,907 |
Accounts receivable, net | 9,999 | 3,827 |
Inventories | 5,282 | 5,159 |
Prepaid expenses and other current assets | 3,080 | 791 |
Total current assets | 44,345 | 23,073 |
Property and equipment, net | 3,914 | 3,807 |
Operating lease assets | 1,346 | 1,038 |
Goodwill | 4,430 | 4,372 |
Intangible assets, net | 1,112 | 1,676 |
Deferred income tax assets | 6,081 | 3,396 |
Other assets | 4,500 | 3,820 |
Total assets | 65,728 | 41,182 |
Current liabilities: | ||
Accounts payable | 2,699 | 1,193 |
Accrued and other current liabilities | 6,682 | 4,120 |
Short-term debt | 1,250 | 1,250 |
Total current liabilities | 10,631 | 6,563 |
Long-term debt | 8,459 | 9,703 |
Long-term operating lease liabilities | 1,119 | 902 |
Other long-term liabilities | 2,541 | 1,913 |
Total liabilities | 22,750 | 19,081 |
Commitments and contingencies - see Note 13 | ||
Shareholders’ equity: | ||
Preferred stock, $0.001 par value; 2 shares authorized; none issued | 0 | 0 |
Common stock, $0.001 par value; 8,000 shares authorized; 2,464 shares issued and outstanding as of January 28, 2024; 2,466 shares issued and outstanding as of January 29, 2023 | 2 | 2 |
Additional paid-in capital | 13,132 | 11,971 |
Accumulated other comprehensive income (loss) | 27 | (43) |
Retained earnings | 29,817 | 10,171 |
Total shareholders' equity | 42,978 | 22,101 |
Total liabilities and shareholders' equity | $ 65,728 | $ 41,182 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Millions | Jan. 28, 2024 | Jan. 29, 2023 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in USD per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 2 | 2 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Common stock, par value (in USD per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 8,000 | 8,000 |
Common stock, shares issued (in shares) | 2,464 | 2,466 |
Common stock, shares outstanding (in shares) | 2,464 | 2,466 |
Consolidated Statements of Shar
Consolidated Statements of Shareholders' Equity - USD ($) shares in Millions, $ in Millions | Total | Common Stock Outstanding | Additional Paid-in Capital | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Retained Earnings |
Beginning balance, common stock outstanding (in shares) at Jan. 31, 2021 | 2,479 | |||||
Beginning balances, shareholders' equity at Jan. 31, 2021 | $ 16,893 | $ 3 | $ 8,719 | $ (10,756) | $ 19 | $ 18,908 |
Increase (Decrease) in Shareholders' Equity | ||||||
Net income | 9,752 | 9,752 | ||||
Other comprehensive (loss) income | (30) | (30) | ||||
Issuance of common stock from stock plans (in shares) | 35 | |||||
Issuance of common stock from stock plans | 281 | 281 | ||||
Tax withholding related to vesting of restricted stock units (in shares) | (8) | |||||
Tax withholding related to vesting of restricted stock units | (1,904) | (614) | (1,290) | |||
Cash dividends declared and paid | (399) | (399) | ||||
Fair value of partially vested equity awards assumed in connection with acquisitions | 18 | 18 | ||||
Stock-based compensation | 2,001 | 2,001 | ||||
Retirement of Treasury Stock | 0 | (20) | 12,046 | (12,026) | ||
Ending balance, common stock outstanding (in shares) at Jan. 30, 2022 | 2,506 | |||||
Ending balances, shareholders' equity at Jan. 30, 2022 | $ 26,612 | $ 3 | 10,385 | 0 | (11) | 16,235 |
Increase (Decrease) in Shareholders' Equity | ||||||
Cash dividends declared and paid (USD per common share) | $ 0.16 | |||||
Net income | $ 4,368 | 4,368 | ||||
Other comprehensive (loss) income | (32) | (32) | ||||
Issuance of common stock from stock plans (in shares) | 31 | |||||
Issuance of common stock from stock plans | 355 | 355 | ||||
Tax withholding related to vesting of restricted stock units (in shares) | (8) | |||||
Tax withholding related to vesting of restricted stock units | (1,475) | (1,475) | ||||
Share repurchased (in shares) | (63) | |||||
Shares repurchased | (10,039) | $ (1) | (4) | (10,034) | ||
Cash dividends declared and paid | (398) | (398) | ||||
Stock-based compensation | $ 2,710 | 2,710 | ||||
Ending balance, common stock outstanding (in shares) at Jan. 29, 2023 | 2,466 | 2,466 | ||||
Ending balances, shareholders' equity at Jan. 29, 2023 | $ 22,101 | $ 2 | 11,971 | 0 | (43) | 10,171 |
Increase (Decrease) in Shareholders' Equity | ||||||
Cash dividends declared and paid (USD per common share) | $ 0.16 | |||||
Net income | $ 29,760 | 29,760 | ||||
Other comprehensive (loss) income | 70 | 70 | ||||
Issuance of common stock from stock plans (in shares) | 26 | |||||
Issuance of common stock from stock plans | 403 | 403 | ||||
Tax withholding related to vesting of restricted stock units (in shares) | (7) | |||||
Tax withholding related to vesting of restricted stock units | $ (2,783) | (2,783) | ||||
Share repurchased (in shares) | (21) | (21) | ||||
Shares repurchased | $ (9,746) | (27) | (9,719) | |||
Cash dividends declared and paid | (395) | (395) | ||||
Stock-based compensation | $ 3,568 | 3,568 | ||||
Ending balance, common stock outstanding (in shares) at Jan. 28, 2024 | 2,464 | 2,464 | ||||
Ending balances, shareholders' equity at Jan. 28, 2024 | $ 42,978 | $ 2 | $ 13,132 | $ 0 | $ 27 | $ 29,817 |
Increase (Decrease) in Shareholders' Equity | ||||||
Cash dividends declared and paid (USD per common share) | $ 0.16 |
Consolidated Statements of Sh_2
Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Statement of Stockholders' Equity [Abstract] | |||
Cash dividends declared and paid (USD per common share) | $ 0.16 | $ 0.16 | $ 0.16 |
Cash dividends declared and paid (USD per common share) | $ 0.16 | $ 0.16 | $ 0.16 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Cash flows from operating activities: | |||
Net income | $ 29,760 | $ 4,368 | $ 9,752 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Stock-based compensation expense | 3,549 | 2,709 | 2,004 |
Depreciation and amortization | 1,508 | 1,544 | 1,174 |
Deferred income taxes | (2,489) | (2,164) | (406) |
(Gains) losses on investments in non-affiliated entities, net | (238) | 45 | (100) |
Acquisition termination cost | 0 | 1,353 | 0 |
Other | (278) | (7) | 47 |
Changes in operating assets and liabilities, net of acquisitions: | |||
Accounts receivable | (6,172) | 822 | (2,215) |
Inventories | (98) | (2,554) | (774) |
Prepaid expenses and other assets | (1,522) | (1,517) | (1,715) |
Accounts payable | 1,531 | (551) | 568 |
Accrued and other current liabilities | 2,025 | 1,341 | 581 |
Other long-term liabilities | 514 | 252 | 192 |
Net cash provided by operating activities | 28,090 | 5,641 | 9,108 |
Cash flows from investing activities: | |||
Proceeds from maturities of marketable securities | 9,732 | 19,425 | 15,197 |
Proceeds from sales of marketable securities | 50 | 1,806 | 1,023 |
Purchases of marketable securities | (18,211) | (11,897) | (24,787) |
Purchases related to property and equipment and intangible assets | (1,069) | (1,833) | (976) |
Acquisitions, net of cash acquired | (83) | (49) | (263) |
Investments in non-affiliated entities and other, net | (985) | (77) | (24) |
Net cash provided by (used in) investing activities | (10,566) | 7,375 | (9,830) |
Cash flows from financing activities: | |||
Proceeds related to employee stock plans | 403 | 355 | 281 |
Payments related to repurchases of common stock | (9,533) | (10,039) | 0 |
Payments related to tax on restricted stock units | (2,783) | (1,475) | (1,904) |
Repayment of debt | (1,250) | 0 | (1,000) |
Dividends paid | (395) | (398) | (399) |
Principal payments on property and equipment and intangible assets | (74) | (58) | (83) |
Issuance of debt, net of issuance costs | 0 | 0 | 4,977 |
Other | (1) | (2) | (7) |
Net cash provided by (used in) financing activities | (13,633) | (11,617) | 1,865 |
Change in cash and cash equivalents | 3,891 | 1,399 | 1,143 |
Cash and cash equivalents at beginning of period | 3,389 | 1,990 | 847 |
Cash and cash equivalents at end of period | 7,280 | 3,389 | 1,990 |
Supplemental disclosures of cash flow information: | |||
Cash paid for income taxes, net | 6,549 | 1,404 | 396 |
Cash paid for interest | $ 252 | $ 254 | $ 246 |
Organization and Summary of Sig
Organization and Summary of Significant Accounting Policies | 12 Months Ended |
Jan. 28, 2024 | |
Accounting Policies [Abstract] | |
Organization and Summary of Significant Accounting Policies | Organization and Summary of Significant Accounting Policies Our Company Headquartered in Santa Clara, California, NVIDIA was incorporated in California in April 1993 and reincorporated in Delaware in April 1998. All references to “NVIDIA,” “we,” “us,” “our” or the “Company” mean NVIDIA Corporation and its subsidiaries. Fiscal Year We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal years 2024, 2023 and 2022 were all 52-week years. Principles of Consolidation Our consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, cash equivalents and marketable securities, accounts receivable, inventories and product purchase commitments, income taxes, goodwill, stock-based compensation, litigation, investigation and settlement costs, restructuring and other charges, property, plant, and equipment, and other contingencies. These estimates are based on historical facts and various other assumptions that we believe are reasonable. In February 2023, we assessed the useful lives of our property, plant, and equipment. Based on advances in technology and usage rate, we increased the estimated useful life of most of our server, storage, and network equipment from three four five Revenue Recognition We derive our revenue from product sales, including hardware and systems, license and development arrangements, software licensing, and cloud services. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract (where revenue is allocated on a relative standalone selling price basis by maximizing the use of observable inputs to determine the standalone selling price for each performance obligation); and (5) recognition of revenue when, or as, we satisfy a performance obligation. Product Sales Revenue Revenue from product sales is recognized upon transfer of control of products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. Certain products are sold with support or an extended warranty for the incorporated system, hardware, and/or software. Support and extended warranty revenue are recognized ratably over the service period, or as services are performed. Revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers. For products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. However, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to accurately reflect our estimated exposure for product returns. Our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and marketing development funds, or MDFs, which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners’ activities while also promoting NVIDIA products. We account for customer programs as a reduction to revenue and accrue for such programs for potential rebates and MDFs based on the amount we expect to be claimed by customers. License and Development Arrangements Our license and development arrangements with customers typically require significant customization of our IP components. As a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. We measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. If a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period. Software Licensing Our software licenses provide our customers with a right to use the software when it is made available to the customer. Customers may purchase either perpetual licenses or subscriptions to licenses, which differ mainly in the duration over which the customer benefits from the software. Software licenses are frequently sold along with the right to receive, on a when-and-if available basis, future unspecified software updates and upgrades. Revenue from software licenses is recognized up front when the software is made available to the customer. Software support revenue is recognized ratably over the service period, or as services are performed. Cloud Services Cloud services, which allow customers to use hosted software and hardware infrastructure without taking possession of the software or hardware, are provided on a subscription basis or a combination of subscription plus usage. Revenue related to subscription-based cloud services is recognized ratably over the contract period. Revenue related to cloud services based on usage is recognized as usage occurs. Cloud services are typically sold on a standalone basis, but certain offerings may be sold with hardware and/or software and related support. Contracts with Multiple Performance Obligations Our contracts may contain more than one of the products and services listed above, each of which is separately accounted for as a distinct performance obligation. We account for multiple agreements with a single customer as a single contract if the contractual terms and/or substance of those agreements indicate that they may be so closely related that they are, in effect, parts of a single contract. We allocate the total transaction price to each distinct performance obligation in a multiple performance obligations arrangement on a relative standalone selling price basis. The standalone selling price reflects the price we would charge for a specific product or service if it were sold separately in similar circumstances and to similar customers. When determining standalone selling price, we maximize the use of observable inputs. If a contract contains a single performance obligation, no allocation is required. Product Warranties We offer a limited warranty to end-users ranging from one Stock-based Compensation We use the closing trading price of our common stock on the date of grant, minus a dividend yield discount, as the fair value of awards of restricted stock units, or RSUs, and performance stock units that are based on our corporate financial performance targets, or PSUs. We use a Monte Carlo simulation on the date of grant to estimate the fair value of performance stock units that are based on market conditions, or market-based PSUs. The compensation expense for RSUs and market-based PSUs is recognized using a straight-line attribution method over the requisite employee service period while compensation expense for PSUs is recognized using an accelerated amortization model. We estimate the fair value of shares to be issued under our employee stock purchase plan, or ESPP, using the Black-Scholes model at the commencement of an offering period in March and September of each year. Stock-based compensation for our ESPP is expensed using an accelerated amortization model. Additionally, for RSU, PSU, and market-based PSU awards, we estimate forfeitures semi-annually and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates. Forfeitures are estimated based on historical experience. Litigation, Investigation and Settlement Costs We currently, are, and will likely continue to be subject to claims, litigation, and other actions, including potential regulatory proceedings, involving patent and other intellectual property matters, taxes, labor and employment, competition and antitrust, commercial disputes, goods and services offered by us and by third parties, and other matters. There are many uncertainties associated with any litigation or investigation, and we cannot be certain that these actions or other third-party claims against us will be resolved without litigation, fines and/or substantial settlement payments or judgments. If information becomes available that causes us to determine that a loss in any of our pending litigation, investigations or settlements is probable, and we can reasonably estimate the loss associated with such events, we will record the loss in accordance with U.S. GAAP. However, the actual liability in any such litigation or investigation may be materially different from our estimates, which could require us to record additional costs. Foreign Currency Remeasurement We use the U.S. dollar as our functional currency for our subsidiaries. Foreign currency monetary assets and liabilities are remeasured into United States dollars at end-of-period exchange rates. Non-monetary assets and liabilities such as property and equipment and equity are remeasured at historical exchange rates. Revenue and expenses are remeasured at exchange rates in effect during each period, except for those expenses related to non-monetary balance sheet amounts, which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in earnings in our Consolidated Statements of Income and to date have not been significant. Income Taxes We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized. Our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. Our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the U.S., or foreign jurisdictions where we operate, or changes in other facts or circumstances. In addition, we recognize liabilities for potential U.S. and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. If we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly. As of January 28, 2024, we had a valuation allowance of $1.6 billion related to capital loss carryforwards, and certain state and other deferred tax assets that management determined are not likely to be realized due, in part, to jurisdictional projections of future taxable income, including capital gains. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as income tax benefits during the period. We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense. Net Income Per Share Basic net income per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common and potentially dilutive shares outstanding during the period, using the treasury stock method. Any anti-dilutive effect of equity awards outstanding is not included in the computation of diluted net income per share. Cash and Cash Equivalents and Marketable Securities We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We currently classify our investments as current based on the nature of the investments and their availability for use in current operations. We classify our cash equivalents and marketable securities related to debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income (expense), net, section of our Consolidated Statements of Income. Available-for-sale debt investments are subject to a periodic impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or we intend to sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the other income (expense), net section of our Consolidated Statements of Income. Fair Value of Financial Instruments The carrying value of cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their relatively short maturities as of January 28, 2024 and January 29, 2023. Marketable securities are comprised of available-for-sale securities that are reported at fair value with the related unrealized gains or losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. Fair value of the marketable securities is determined based on quoted market prices. Derivative instruments are recognized as either assets or liabilities and are measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. For derivative instruments designated as fair value hedges, the gains or losses are recognized in earnings in the periods of change together with the offsetting losses or gains on the hedged items attributed to the risk being hedged. For derivative instruments designated as cash-flow hedges, the effective portion of the gains or losses on the derivatives is initially reported as a component of other comprehensive income or loss and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments not designated for hedge accounting, changes in fair value are recognized in earnings. Concentration of Credit Risk Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, marketable securities, and accounts receivable. Our investment policy requires the purchase of highly-rated fixed income securities, the diversification of investment type and credit exposures, and includes certain limits on our portfolio duration. We perform ongoing credit evaluations of our customers’ financial condition and maintain an allowance for potential credit losses. This allowance consists of an amount identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance and letters of credit. Inventories Inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. Inventory costs consist primarily of the cost of semiconductors, including wafer fabrication, assembly, testing and packaging, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, and shipping costs, as well as the cost of purchased memory products and other component parts. We charge cost of sales for inventory provisions to write-down our inventory to the lower of cost or net realizable value or for obsolete or excess inventory, and for excess product purchase commitments. Most of our inventory provisions relate to excess quantities of products, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and market conditions. Once inventory has been written-off or written-down, it creates a new cost basis for the inventory that is not subsequently written-up. We record a liability for noncancelable purchase commitments with suppliers for quantities in excess of our future demand forecasts consistent with our valuation of obsolete or excess inventory. Property and Equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method based on the estimated useful lives of the assets of three Leases We determine if an arrangement is or contains a lease at inception. Operating leases with lease terms of more than 12 months are included in operating lease assets, accrued and other current liabilities, and long-term operating lease liabilities on our consolidated balance sheet. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term. Operating lease assets and liabilities are recognized based on the present value of the remaining lease payments discounted using our incremental borrowing rate. Operating lease assets also include initial direct costs incurred and prepaid lease payments, minus any lease incentives. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense is recognized on a straight-line basis over the lease term. We combine the lease and non-lease components in determining the operating lease assets and liabilities. Goodwill Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier if indicators of potential impairment exist. In completing our impairment test, we perform either a qualitative or a quantitative analysis on a reporting unit basis. Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting units. The quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit’s fair value. The income and market valuation approaches consider factors that include, but are not limited to, prospective financial information, growth rates, residual values, discount rates and comparable multiples from publicly traded companies in our industry and require us to make certain assumptions and estimates regarding industry economic factors and the future profitability of our business. Intangible Assets and Other Long-Lived Assets Intangible assets primarily represent acquired intangible assets including developed technology and customer relationships, as well as rights acquired under technology licenses, patents, and acquired IP. We currently amortize our intangible assets with finite lives over periods ranging from one Long-lived assets, such as property and equipment and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. The recoverability of assets or asset groups to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the estimated fair value of the asset or asset group. Fair value is determined based on the estimated discounted future cash flows expected to be generated by the asset or asset group. Assets and liabilities to be disposed of would be separately presented in the Consolidated Balance Sheet and the assets would be reported at the lower of the carrying amount or fair value less costs to sell, and would no longer be depreciated. Business Combination We allocate the fair value of the purchase price of an acquisition to the tangible assets acquired, liabilities assumed, and intangible assets acquired, based on their estimated fair values. The excess of the fair value of the purchase price over the fair values of these net tangible and intangible assets acquired is recorded as goodwill. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but our estimates and assumptions are inherently uncertain and subject to refinement. The estimates and assumptions used in valuing intangible assets include, but are not limited to, the amount and timing of projected future cash flows, discount rate used to determine the present value of these cash flows and asset lives. These estimates are inherently uncertain and, therefore, actual results may differ from the estimates made. As a result, during the measurement period of up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the measurement period's conclusion or final determination of the fair value of the purchase price of an acquisition, whichever comes first, any subsequent adjustments are recorded to our Consolidated Statements of Income. Acquisition-related expenses are recognized separately from the business combination and expensed as incurred. Investments in Non-Affiliated Entities Our investment in non-affiliates consists of marketable equity securities, which are publicly traded, and non-marketable equity securities, which are investments in privately held companies. Marketable equity securities have readily determinable fair values with changes in fair value recorded in other income (expense), net. Non-marketable equity securities include investments that do not have a readily determinable fair value. The investments that do not have readily determinable fair value are measured at cost minus impairment, if any, and are adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment in the same issuer, or the measurement alternative. Fair value is based upon observable inputs in an inactive market and the valuation requires our judgment due to the absence of market prices and inherent lack of liquidity. All gains and losses on these investments, realized and unrealized, are recognized in other income (expense), net on our Consolidated Statements of Income. We assess whether an impairment loss has occurred on our investments in non-marketable equity securities, accounted for under the measurement alternative based on quantitative and qualitative factors. If any impairment is identified for non-marketable equity securities, we write down the investment to its fair value and record the corresponding charge through other income (expense), net on our Consolidated Statements of Income. Recently Issued Accounting Pronouncements Recent Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board, or FASB, issued a new accounting standard to provide for additional disclosures about significant expenses in operating segments. The standard is effective for our annual reporting for fiscal year 2025 and for interim period reporting starting in fiscal year 2026 retrospectively. We are currently evaluating the impact of this standard on our Consolidated Financial Statements. In December 2023, the FASB issued a new accounting standard which provides for new and changes to income tax disclosures including disaggregation of the rate reconciliation and income taxes paid disclosures. The amendments in the standard are effective for annual periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively, with retrospective application permitted. We expect to adopt this standard in our annual period beginning fiscal year 2026. We are currently evaluating the impact of this standard on our Consolidated Financial Statements. |
Business Combination
Business Combination | 12 Months Ended |
Jan. 28, 2024 | |
Business Combination and Asset Acquisition [Abstract] | |
Business Combination | Business Combination Termination of the Arm Share Purchase Agreement In February 2022, NVIDIA and SoftBank Group Corp, or SoftBank, announced the termination of the Share Purchase Agreement whereby NVIDIA would have acquired Arm from SoftBank. The parties agreed to terminate it due to significant regulatory challenges preventing the completion of the transaction. We recorded an acquisition termination cost of $1.4 billion in fiscal year 2023 reflecting the write-off of the prepayment provided at signing. |
Leases
Leases | 12 Months Ended |
Jan. 28, 2024 | |
Leases [Abstract] | |
Leases | Leases Our lease obligations primarily consist of operating leases for our headquarters complex, domestic and international office facilities, and data center space, with lease periods expiring between fiscal years 2025 and 2035. Future minimum lease payments under our non-cancelable operating leases as of January 28, 2024, are as follows: Operating Lease Obligations (In millions) Fiscal Year: 2025 $ 290 2026 270 2027 253 2028 236 2029 202 2030 and thereafter 288 Total 1,539 Less imputed interest 192 Present value of net future minimum lease payments 1,347 Less short-term operating lease liabilities 228 Long-term operating lease liabilities $ 1,119 In addition, we have operating leases, primarily for our data centers, that are expected to commence within fiscal year 2025 with lease terms of 1 to 10 years for $1.1 billion. Operating lease expenses for fiscal years 2024, 2023, and 2022 were $269 million, $193 million, $168 million, respectively. Short-term and variable lease expenses for fiscal years 2024, 2023, and 2022 were not significant. Other information related to leases was as follows: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) Supplemental cash flows information Operating cash flows used for operating leases $ 286 $ 184 $ 154 Operating lease assets obtained in exchange for lease obligations $ 531 $ 358 $ 266 As of January 28, 2024, our operating leases had a weighted average remaining lease term of 6.1 years and a weighted average discount rate of 3.76%. As of January 29, 2023, our operating leases had a weighted average remaining lease term of 6.8 years and a weighted average discount rate of 3.21%. |
Stock-Based Compensation
Stock-Based Compensation | 12 Months Ended |
Jan. 28, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation Our stock-based compensation expense is associated with RSUs, performance stock units based on our corporate financial performance targets, or PSUs, performance stock units based on market conditions, or market-based PSUs, and our ESPP. Our Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) Cost of revenue $ 141 $ 138 $ 141 Research and development 2,532 1,892 1,298 Sales, general and administrative 876 680 565 Total $ 3,549 $ 2,710 $ 2,004 Stock-based compensation capitalized in inventories was not significant during fiscal years 2024, 2023, and 2022. The following is a summary of equity awards granted under our equity incentive plans: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions, except per share data) RSUs, PSUs and Market-based PSUs Awards granted 14 25 18 Estimated total grant-date fair value $ 5,316 $ 4,505 $ 3,492 Weighted average grant-date fair value per share $ 374.08 $ 183.72 $ 190.69 ESPP Shares purchased 3 3 5 Weighted average price per share $ 158.07 $ 122.54 $ 56.36 Weighted average grant-date fair value per share $ 69.90 $ 51.87 $ 23.24 As of January 28, 2024, there was $8.6 billion of aggregate unearned stock-based compensation expense. This amount is expected to be recognized over a weighted average period of 2.5 years for RSUs, PSUs, and market-based PSUs, and 0.8 years for ESPP. The fair value of shares issued under our ESPP have been estimated with the following assumptions: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (Using the Black-Scholes model) ESPP Weighted average expected life (in years) 0.1-2.0 0.1-2.0 0.1-2.0 Risk-free interest rate 3.9%-5.5% —%-4.6% —%-0.5% Volatility 31%-67% 43%-72% 20%-58% Dividend yield 0.1% 0.1% 0.1% For ESPP shares, the expected term represents the average term from the first day of the offering period to the purchase date. The risk-free interest rate assumption used to value ESPP shares is based upon observed interest rates on Treasury bills appropriate for the expected term. Our expected stock price volatility assumption for ESPP is estimated using historical volatility. For awards granted, we use the dividend yield at grant date. Our RSU, PSU, and market-based PSU awards are not eligible for cash dividends prior to vesting; therefore, the fair values of RSUs, PSUs, and market-based PSUs are discounted for the dividend yield. Additionally, for RSU, PSU, and market-based PSU awards, we estimate forfeitures semi-annually and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates. Forfeitures are estimated based on historical experience. Equity Incentive Program We grant or have granted stock options, RSUs, PSUs, market-based PSUs, and stock purchase rights under the following equity incentive plans. In addition, in connection with our acquisitions of various companies, we have assumed certain stock-based awards granted under their stock incentive plans and converted them into our RSUs. Amended and Restated 2007 Equity Incentive Plan In 2007, our shareholders approved the NVIDIA Corporation 2007 Equity Incentive Plan, or as most recently amended and restated, the 2007 Plan. The 2007 Plan authorizes the issuance of incentive stock options, non-statutory stock options, restricted stock, RSUs, stock appreciation rights, performance stock awards, performance cash awards, and other stock-based awards to employees, directors and consultants. Only our employees may receive incentive stock options. As of January 28, 2024, up to 37 million shares of our common stock could be issued pursuant to stock awards granted under the 2007 Plan. Currently, we grant RSUs, PSUs and market-based PSUs under the 2007 Plan, under which, as of January 28, 2024, there were 147 million shares available for future grants. Subject to certain exceptions, RSUs granted to employees vest (A) over a four-year period, subject to continued service, with 25% vesting on a pre-determined date that is close to the anniversary of the date of grant and 6.25% vesting quarterly thereafter, (B) over a three-year period, subject to continued service, with 40% vesting on a pre-determined date that is close to the anniversary of the date of grant and 7.5% vesting quarterly thereafter, or (C) over a four-year period, subject to continued service, with 6.25% vesting quarterly. PSUs vest over a four-year period, subject to continued service, with 25% vesting on a pre-determined date that is close to the anniversary of the date of grant and 6.25% vesting quarterly thereafter. Market-based PSUs vest 100% on about the three-year anniversary of the date of grant. However, the number of shares subject to both PSUs and market-based PSUs that are eligible to vest is determined by the Compensation Committee based on achievement of pre-determined criteria. Amended and Restated 2012 Employee Stock Purchase Plan In 2012, our shareholders approved the NVIDIA Corporation 2012 Employee Stock Purchase Plan, or as most recently amended and restated, the 2012 Plan. Employees who participate in the 2012 Plan may have up to 15% of their earnings withheld to purchase shares of common stock. The Board may decrease this percentage at its discretion. Each offering period is about 24 months, divided into four purchase periods of six months. The price of common stock purchased under our 2012 Plan will be equal to 85% of the lower of the fair market value of the common stock on the commencement date of each offering period or the fair market value of the common stock on each purchase date within the offering. As of January 28, 2024, we had 227 million shares reserved for future issuance under the 2012 Plan. Equity Award Activity The following is a summary of our equity award transactions under our equity incentive plans: RSUs, PSUs and Market-based PSUs Outstanding Number of Shares Weighted Average Grant-Date Fair Value (In millions, except per share data) Balances, Jan 29, 2023 45 $ 158.45 Granted 14 $ 374.08 Vested restricted stock (21) $ 148.56 Canceled and forfeited (1) $ 206.35 Balances, Jan 28, 2024 37 $ 245.94 Vested and expected to vest after Jan 28, 2024 37 $ 245.49 As of January 28, 2024 and January 29, 2023, there were 147 million and 160 million shares, respectively, of common stock available for future grants under our equity incentive plans. The total fair value of RSUs and PSUs, as of their respective vesting dates, during the years ended January 28, 2024, January 29, 2023, and January 30, 2022, was $8.2 billion, $4.3 billion, and $5.6 billion, respectively. |
Net Income Per Share
Net Income Per Share | 12 Months Ended |
Jan. 28, 2024 | |
Earnings Per Share [Abstract] | |
Net Income Per Share | Net Income Per Share The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions, except per share data) Numerator: Net income $ 29,760 $ 4,368 $ 9,752 Denominator: Basic weighted average shares 2,469 2,487 2,496 Dilutive impact of outstanding equity awards 25 20 39 Diluted weighted average shares 2,494 2,507 2,535 Net income per share: Basic (1) $ 12.05 $ 1.76 $ 3.91 Diluted (2) $ 11.93 $ 1.74 $ 3.85 Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive 15 40 21 (1) Calculated as net income divided by basic weighted average shares. (2) Calculated as net income divided by diluted weighted average shares. |
Goodwill
Goodwill | 12 Months Ended |
Jan. 28, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill | GoodwillAs of January 28, 2024, the total carrying amount of goodwill was $4.4 billion, consisting of goodwill balances allocated to our Compute & Networking and Graphics reporting units of $4.1 billion and $370 million, respectively. As of January 29, 2023, the total carrying amount of goodwill was $4.4 billion, consisting of goodwill balances allocated to our Compute & Networking and Graphics reporting units of $4.0 billion and $370 million, respectively. Goodwill increased by $59 million in fiscal year 2024 from an immaterial acquisition and was allocated to our Compute & Networking reporting unit. During the fourth quarters of fiscal years 2024, 2023, and 2022, we completed our annual qualitative impairment tests and concluded that goodwill was not impaired. |
Amortizable Intangible Assets
Amortizable Intangible Assets | 12 Months Ended |
Jan. 28, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Amortizable Intangible Assets | Amortizable Intangible Assets The components of our amortizable intangible assets are as follows: Jan 28, 2024 Jan 29, 2023 Gross Carrying Amount Accumulated Net Gross Carrying Amount Accumulated Net (In millions) Acquisition-related intangible assets (1) $ 2,642 $ (1,720) $ 922 $ 3,093 $ (1,614) $ 1,479 Patents and licensed technology 449 (259) 190 446 (249) 197 Total intangible assets $ 3,091 $ (1,979) $ 1,112 $ 3,539 $ (1,863) $ 1,676 (1) During the first quarter of fiscal year 2023, we commenced amortization of a $630 million in-process research and development intangible asset related to our acquisition of Mellanox. Amortization expense associated with intangible assets for fiscal years 2024, 2023, and 2022 was $614 million, $699 million, and $563 million, respectively. The following table outlines the estimated future amortization expense related to the net carrying amount of intangible assets as of January 28, 2024: Future Amortization Expense (In millions) Fiscal Year: 2025 $ 555 2026 261 2027 150 2028 37 2029 9 2030 and thereafter 100 Total $ 1,112 |
Cash Equivalents and Marketable
Cash Equivalents and Marketable Securities | 12 Months Ended |
Jan. 28, 2024 | |
Investments, Debt and Equity Securities [Abstract] | |
Cash Equivalents and Marketable Securities | Cash Equivalents and Marketable Securities Our cash equivalents and marketable securities related to debt securities are classified as “available-for-sale” debt securities. The following is a summary of cash equivalents and marketable securities: Jan 28, 2024 Amortized Unrealized Unrealized Estimated Reported as Cash Equivalents Marketable Securities (In millions) Corporate debt securities $ 10,126 $ 31 $ (5) $ 10,152 $ 2,231 $ 7,921 Debt securities issued by the U.S. Treasury 9,517 17 (10) 9,524 1,315 8,209 Debt securities issued by U.S. government agencies 2,326 8 (1) 2,333 89 2,244 Money market funds 3,031 — — 3,031 3,031 — Certificates of deposit 510 — — 510 294 216 Foreign government bonds 174 — — 174 60 114 Total $ 25,684 $ 56 $ (16) $ 25,724 $ 7,020 $ 18,704 Jan 29, 2023 Amortized Unrealized Unrealized Estimated Reported as Cash Equivalents Marketable Securities (In millions) Corporate debt securities $ 4,809 $ — $ (12) $ 4,797 $ 1,087 $ 3,710 Debt securities issued by the U.S. Treasury 4,185 1 (44) 4,142 — 4,142 Debt securities issued by U.S. government agencies 1,836 — (2) 1,834 50 1,784 Money market funds 1,777 — — 1,777 1,777 — Certificates of deposit 365 — — 365 134 231 Foreign government bonds 140 — — 140 100 40 Total $ 13,112 $ 1 $ (58) $ 13,055 $ 3,148 $ 9,907 The following tables provide the breakdown of unrealized losses, aggregated by investment category and length of time that individual securities have been in a continuous loss position: Jan 28, 2024 Less than 12 Months 12 Months or Greater Total Estimated Fair Value Gross Unrealized Loss Estimated Fair Value Gross Unrealized Loss Estimated Fair Value Gross Unrealized Loss (In millions) Debt securities issued by the U.S. Treasury $ 3,343 $ (5) $ 1,078 $ (5) $ 4,421 $ (10) Corporate debt securities 1,306 (3) 618 (2) 1,924 (5) Debt securities issued by U.S. government agencies 670 (1) — — 670 (1) Total $ 5,319 $ (9) $ 1,696 $ (7) $ 7,015 $ (16) Jan 29, 2023 Less than 12 Months 12 Months or Greater Total Estimated Fair Value Gross Unrealized Loss Estimated Fair Value Gross Unrealized Loss Estimated Fair Value Gross Unrealized Loss (In millions) Debt securities issued by the U.S. Treasury $ 2,444 $ (21) $ 1,172 $ (23) $ 3,616 $ (44) Corporate debt securities 1,188 (7) 696 (5) 1,884 (12) Debt securities issued by U.S. government agencies 1,307 (2) — — 1,307 (2) Total $ 4,939 $ (30) $ 1,868 $ (28) $ 6,807 $ (58) The gross unrealized losses are related to fixed income securities, driven primarily by changes in interest rates. Net realized gains and losses were not significant for all periods presented. The amortized cost and estimated fair value of cash equivalents and marketable securities are shown below by contractual maturity. Jan 28, 2024 Jan 29, 2023 Amortized Estimated Amortized Estimated (In millions) Less than one year $ 16,336 $ 16,329 $ 9,738 $ 9,708 Due in 1 - 5 years 9,348 9,395 3,374 3,347 Total $ 25,684 $ 25,724 $ 13,112 $ 13,055 |
Fair Value of Financial Assets
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities | 12 Months Ended |
Jan. 28, 2024 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities | Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities The fair values of our financial assets and liabilities are determined using quoted market prices of identical assets or quoted market prices of similar assets from active markets. We review fair value hierarchy classification on a quarterly basis. Fair Value at Pricing Category Jan 28, 2024 Jan 29, 2023 (In millions) Assets Cash equivalents and marketable securities: Money market funds Level 1 $ 3,031 $ 1,777 Corporate debt securities Level 2 $ 10,152 $ 4,797 Debt securities issued by the U.S. Treasury Level 2 $ 9,524 $ 4,142 Debt securities issued by U.S. government agencies Level 2 $ 2,333 $ 1,834 Certificates of deposit Level 2 $ 510 $ 365 Foreign government bonds Level 2 $ 174 $ 140 Other assets (Investment in non-affiliated entities): Publicly-held equity securities Level 1 $ 225 $ 11 Liabilities (1) 0.309% Notes Due 2023 Level 2 $ — $ 1,230 0.584% Notes Due 2024 Level 2 $ 1,228 $ 1,185 3.20% Notes Due 2026 Level 2 $ 970 $ 966 1.55% Notes Due 2028 Level 2 $ 1,115 $ 1,099 2.85% Notes Due 2030 Level 2 $ 1,367 $ 1,364 2.00% Notes Due 2031 Level 2 $ 1,057 $ 1,044 3.50% Notes Due 2040 Level 2 $ 851 $ 870 3.50% Notes Due 2050 Level 2 $ 1,604 $ 1,637 3.70% Notes Due 2060 Level 2 $ 403 $ 410 (1) These liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs. Investments in Non-Affiliated Entities Our investments in non-affiliated entities include marketable equity securities, which are publicly traded, and non-marketable equity securities, which are primarily investments in privately held companies. Our marketable equity securities have readily determinable fair values and are recorded as long-term other assets on our Consolidated Balance Sheets at fair value with changes in fair value recorded in Other income and expense, net on our Consolidated Statements of Income. Marketable equity securities totaled $225 million and $11 million as of January 28, 2024 and January 29, 2023, respectively. The net unrealized and realized gains and losses of investments in marketable securities net were not significant for fiscal years 2024, 2023 and 2022. Our non-marketable equity securities are recorded in long-term other assets on our Consolidated Balance Sheets. The carrying value of our non-marketable equity securities totaled $1.3 billion and $288 million as of January 28, 2024 and January 29, 2023, respectively. Gains and losses on these investments, realized and unrealized, are recognized in Other income and expense, net on our Consolidated Statements of Income. Adjustments to the carrying value of our non-marketable equity securities accounted for under the measurement alternative were as follows: Year Ended Jan 28, 2024 (In millions) Carrying amount as of Jan 29, 2023 $ 288 Adjustments related to non-marketable equity securities: Net additions 859 Unrealized gains 194 Impairments and unrealized losses (20) Carrying amount as of Jan 28, 2024 $ 1,321 In the fourth quarter of fiscal year 2024, one of our private company investments completed a secondary equity raise that resulted in an unrealized gain of $178 million. Net unrealized gains recognized for the year ended January 28, 2024 for non-marketable investments in non-affiliated entities still held as of January 28, 2024 were $174 million. Net unrealized and realized gains related to non-marketable equity securities were not significant for fiscal years 2023 and 2022. The following table summarizes the cumulative gross unrealized gains and cumulative gross unrealized losses and impairments related to non-marketable equity securities accounted for under the measurement alternative: Jan 28, 2024 (In millions) Cumulative gross unrealized gains $ 270 Cumulative gross unrealized losses and impairments (45) |
Balance Sheet Components
Balance Sheet Components | 12 Months Ended |
Jan. 28, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Balance Sheet Components | Balance Sheet Components Two customers accounted for 24% and 11% of our accounts receivable balance as of January 28, 2024. Two customers accounted for 14% and 11% of our accounts receivable balance as of January 29, 2023. Certain balance sheet components are as follows: Jan 28, 2024 Jan 29, 2023 (In millions) Inventories (1) : Raw materials $ 1,719 $ 2,430 Work in-process 1,505 466 Finished goods 2,058 2,263 Total inventories $ 5,282 $ 5,159 (1) In fiscal years 2024 and 2023, we recorded an inventory provision of $774 million and $1.0 billion, respectively, in cost of revenue. Jan 28, 2024 Jan 29, 2023 Estimated (In millions) (In years) Property and Equipment: Land $ 218 $ 218 (A) Buildings, leasehold improvements, and furniture 1,816 1,598 (B) Equipment, compute hardware, and software 5,200 4,303 3-7 Construction in process 189 382 (C) Total property and equipment, gross 7,423 6,501 Accumulated depreciation and amortization (3,509) (2,694) Total property and equipment, net $ 3,914 $ 3,807 (A) Land is a non-depreciable asset. (B) The estimated useful lives of our buildings are up to thirty years. Leasehold improvements and finance leases are amortized based on the lesser of either the asset’s estimated useful life or the expected remaining lease term. (C) Construction in process represents assets that are not available for their intended use as of the balance sheet date. Depreciation expense for fiscal years 2024, 2023, and 2022 was $894 million, $844 million, and $611 million, respectively. Accumulated amortization of leasehold improvements and finance leases was $400 million and $327 million as of January 28, 2024 and January 29, 2023, respectively. Property, equipment and intangible assets acquired by assuming related liabilities during fiscal years 2024, 2023, and 2022 were $170 million, $374 million, and $258 million, respectively. Jan 28, 2024 Jan 29, 2023 Other assets: (In millions) Prepaid supply and capacity agreements (1) $ 2,458 $ 2,989 Investments in non-affiliated entities 1,546 299 Prepaid royalties 364 387 Other 132 145 Total other assets $ 4,500 $ 3,820 (1) As of January 28, 2024 and January 29, 2023, there was an additional $2.5 billion and $458 million of short-term prepaid supply and capacity agreements included in Prepaid expenses and other current assets, respectively. Jan 28, 2024 Jan 29, 2023 (In millions) Accrued and Other Current Liabilities: Customer program accruals $ 2,081 $ 1,196 Excess inventory purchase obligations (1) 1,655 954 Deferred revenue (2) 764 354 Accrued payroll and related expenses 675 530 Product warranty and return provisions 415 108 Taxes payable 296 467 Operating leases 228 176 Unsettled share repurchases 187 117 Licenses and royalties 182 149 Other 199 69 Total accrued and other current liabilities $ 6,682 $ 4,120 (1) In fiscal years 2024 and 2023, we recorded an expense of approximately $1.4 billion and $1.1 billion, respectively, in cost of revenue for inventory purchase obligations in excess of our current demand projections, supplier charges and for penalties related to cancellations and underutilization. (2) Deferred revenue primarily includes customer advances and deferrals related to support for hardware and software, license and development arrangements, and cloud services. $233 million and $35 million of the balance in fiscal 2024 and 2023 respectively, related to customer advances. Jan 28, 2024 Jan 29, 2023 (In millions) Other Long-Term Liabilities: Income tax payable (1) $ 1,361 $ 1,204 Deferred income tax 462 247 Deferred revenue (2) 573 218 Licenses payable 80 181 Other 65 63 Total other long-term liabilities $ 2,541 $ 1,913 (1) Income tax payable is comprised of the long-term portion of the one-time transition tax payable, unrecognized tax benefits, and related interest and penalties. (2) Deferred revenue primarily includes deferrals related to support for hardware and software. Deferred Revenue The following table shows the changes in deferred revenue during fiscal years 2024 and 2023. Jan 28, 2024 Jan 29, 2023 (In millions) Balance at beginning of period $ 572 $ 502 Deferred revenue additions during the period 2,038 830 Revenue recognized during the period (1,273) (760) Balance at end of period $ 1,337 $ 572 Revenue recognized during fiscal year 2024 that was included in deferred revenue as of January 29, 2023 was $338 million. Revenue recognized during fiscal year 2023 that was included in deferred revenue as of January 30, 2022 was $282 million. Revenue related to remaining performance obligations represents the contracted license and development arrangements and support for hardware and software. This includes deferred revenue currently recorded and amounts that will be invoiced in future periods. Revenue allocated to remaining performance obligations, which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods, was $1.1 billion as of January 28, 2024. We expect to recognize approximately 40% of this revenue over the next twelve months and the remainder thereafter. This excludes revenue related to performance obligations for contracts with a length of one year or less. |
Derivative Financial Instrument
Derivative Financial Instruments | 12 Months Ended |
Jan. 28, 2024 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Financial Instruments | Derivative Financial Instruments We enter into foreign currency forward contracts to mitigate the impact of foreign currency exchange rate movements on our operating expenses. These contracts are designated as cash flow hedges for hedge accounting treatment. Gains or losses on the contracts are recorded in accumulated other comprehensive income or loss and reclassified to operating expense when the related operating expenses are recognized in earnings or ineffectiveness should occur. We also enter into foreign currency forward contracts to mitigate the impact of foreign currency movements on monetary assets and liabilities that are denominated in currencies other than the U.S. dollar. These forward contracts were not designated for hedge accounting treatment. Therefore, the change in fair value of these contracts is recorded in other income or expense and offsets the change in fair value of the hedged foreign currency denominated monetary assets and liabilities, which is also recorded in other income or expense. The table below presents the notional value of our foreign currency forward contracts outstanding: Jan 28, 2024 Jan 29, 2023 (In millions) Designated as cash flow hedges $ 1,168 $ 1,128 Non-designated hedges $ 597 $ 366 The unrealized gains and losses or fair value of our foreign currency forward contracts was not significant as of January 28, 2024 and January 29, 2023. As of January 28, 2024, all designated foreign currency forward contracts mature within 18 months. The expected realized gains and losses deferred into accumulated other comprehensive income or loss related to foreign currency forward contracts within the next twelve months was not significant. During fiscal years 2024 and 2023, the impact of derivative financial instruments designated for hedge accounting treatment on other comprehensive income or loss was not significant and all such instruments were determined to be highly effective. |
Debt
Debt | 12 Months Ended |
Jan. 28, 2024 | |
Debt Disclosure [Abstract] | |
Debt | Debt Long-Term Debt The carrying value of our outstanding notes, the calendar year of maturity, and the associated interest rates were as follows: Expected Effective Jan 28, 2024 Jan 29, 2023 (In millions) 0.309% Notes Due 2023 (1) — 0.41% $ — $ 1,250 0.584% Notes Due 2024 0.4 0.66% 1,250 1,250 3.20% Notes Due 2026 2.6 3.31% 1,000 1,000 1.55% Notes Due 2028 4.4 1.64% 1,250 1,250 2.85% Notes Due 2030 6.2 2.93% 1,500 1,500 2.00% Notes Due 2031 7.4 2.09% 1,250 1,250 3.50% Notes Due 2040 16.2 3.54% 1,000 1,000 3.50% Notes Due 2050 26.2 3.54% 2,000 2,000 3.70% Notes Due 2060 36.2 3.73% 500 500 Unamortized debt discount and issuance costs (41) (47) Net carrying amount 9,709 10,953 Less short-term portion (1,250) (1,250) Total long-term portion $ 8,459 $ 9,703 (1) In fiscal year 2024, we repaid the 0.309% Notes Due 2023. All our notes are unsecured senior obligations. All existing and future liabilities of our subsidiaries will be effectively senior to the notes. Our notes pay interest semi-annually. We may redeem each of our notes prior to maturity, subject to a make-whole premium as defined in the applicable form of note. As of January 28, 2024, we were in compliance with the required covenants, which are non-financial in nature, under the outstanding notes. Commercial Paper We have a $575 million commercial paper program to support general corporate purposes. As of January 28, 2024, we had no commercial paper outstanding. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Jan. 28, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Purchase Obligations Our purchase obligations reflect our commitments to purchase components used to manufacture our products, including long-term supply and capacity agreements, certain software and technology licenses, other goods and services and long-lived assets. As of January 28, 2024, we had outstanding inventory purchase and long-term supply and capacity obligations totaling $16.1 billion. We enter into agreements with contract manufacturers that allow them to procure inventory based upon criteria as defined by us, and in certain instances, these agreements allow us the option to cancel, reschedule, and adjust our requirements based on our business needs prior to firm orders being placed, but these changes may result in the payment of costs incurred through the date of cancellation. Other non-inventory purchase obligations were $4.6 billion, which includes $3.5 billion of multi-year cloud service agreements, primarily to support our research and development efforts. Total future purchase commitments as of January 28, 2024 are as follows: Commitments (In millions) Fiscal Year: 2025 $ 17,316 2026 1,143 2027 1,060 2028 770 2029 and thereafter 418 Total $ 20,707 Accrual for Product Warranty Liabilities The estimated amount of product warranty liabilities was $306 million and $82 million as of January 28, 2024 and January 29, 2023, respectively. The estimated product returns and estimated product warranty activity consisted of the following: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) Balance at beginning of period $ 82 $ 46 $ 22 Additions 278 145 40 Utilization (54) (109) (16) Balance at end of period $ 306 $ 82 $ 46 In fiscal years 2024 and 2023, the additions in product warranty liabilities primarily related to Compute & Networking segment. We have provided indemnities for matters such as tax, product, and employee liabilities. We have included intellectual property indemnification provisions in our technology-related agreements with third parties. Maximum potential future payments cannot be estimated because many of these agreements do not have a maximum stated liability. We have not recorded any liability in our Consolidated Financial Statements for such indemnifications. Litigation Securities Class Action and Derivative Lawsuits The plaintiffs in the putative securities class action lawsuit, captioned 4:18-cv-07669-HSG, initially filed on December 21, 2018 in the United States District Court for the Northern District of California, and titled In Re NVIDIA Corporation Securities Litigation, filed an amended complaint on May 13, 2020. The amended complaint asserted that NVIDIA and certain NVIDIA executives violated Section 10(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and SEC Rule 10b-5, by making materially false or misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand between May 10, 2017 and November 14, 2018. Plaintiffs also alleged that the NVIDIA executives who they named as defendants violated Section 20(a) of the Exchange Act. Plaintiffs sought class certification, an award of unspecified compensatory damages, an award of reasonable costs and expenses, including attorneys’ fees and expert fees, and further relief as the Court may deem just and proper. On March 2, 2021, the district court granted NVIDIA’s motion to dismiss the complaint without leave to amend, entered judgment in favor of NVIDIA and closed the case. On March 30, 2021, plaintiffs filed an appeal from judgment in the United States Court of Appeals for the Ninth Circuit, case number 21-15604. On August 25, 2023, a majority of a three-judge Ninth Circuit panel affirmed in part and reversed in part the district court’s dismissal of the case, with a third judge dissenting on the basis that the district court did not err in dismissing the case. On November 15, 2023, the Ninth Circuit denied NVIDIA’s petition for rehearing en banc of the Ninth Circuit panel’s majority decision to reverse in part the dismissal of the case, which NVIDIA had filed on October 10, 2023. On November 21, 2023, NVIDIA filed a motion with the Ninth Circuit for a stay of the mandate pending NVIDIA’s petition for a writ of certiorari in the Supreme Court of the United States and the Supreme Court’s resolution of the matter. On December 5, 2023, the Ninth Circuit granted NVIDIA’s motion to stay the mandate. NVIDIA’s deadline to file a petition for a writ of certiorari is March 4, 2024. The putative derivative lawsuit pending in the United States District Court for the Northern District of California, captioned 4:19-cv-00341-HSG, initially filed January 18, 2019 and titled In re NVIDIA Corporation Consolidated Derivative Litigation, was stayed pending resolution of the plaintiffs’ appeal in the In Re NVIDIA Corporation Securities Litigation action. On February 22, 2022, the court administratively closed the case, but stated that it would reopen the case once the appeal in the In Re NVIDIA Corporation Securities Litigation action is resolved. Following the Ninth Circuit’s denial of NVIDIA’s petition for rehearing on November 15, 2023, the parties are conferring regarding the next steps in this derivative matter. The lawsuit asserts claims, purportedly on behalf of us, against certain officers and directors of the Company for breach of fiduciary duty, unjust enrichment, waste of corporate assets, and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs are seeking unspecified damages and other relief, including reforms and improvements to NVIDIA’s corporate governance and internal procedures. The putative derivative actions initially filed September 24, 2019 and pending in the United States District Court for the District of Delaware, Lipchitz v. Huang, et al. (Case No. 1:19-cv-01795-UNA) and Nelson v. Huang, et. al. (Case No. 1:19-cv-01798- UNA), remain stayed pending resolution of the plaintiffs’ appeal in the In Re NVIDIA Corporation Securities Litigation action. Following the Ninth Circuit’s denial of NVIDIA’s petition for rehearing on November 15, 2023, the parties are conferring regarding the next steps in these derivative matters. The lawsuits assert claims, purportedly on behalf of us, against certain officers and directors of the Company for breach of fiduciary duty, unjust enrichment, insider trading, misappropriation of information, corporate waste and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false, and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs seek unspecified damages and other relief, including disgorgement of profits from the sale of NVIDIA stock and unspecified corporate governance measures. Another putative derivative action was filed on October 30, 2023 in the Court of Chancery of the State of Delaware, captioned Horanic v. Huang, et al. (Case No. 2023-1096-KSJM). This lawsuit asserts claims, purportedly on behalf of us, against certain officers and directors of the Company for breach of fiduciary duty and insider trading based on the dissemination of allegedly false and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs seek unspecified damages and other relief, including disgorgement of profits from the sale of NVIDIA stock and reform of unspecified corporate governance measures. This derivative matter is stayed pending the final resolution of In Re NVIDIA Corporation Securities Litigation action. Accounting for Loss Contingencies As of January 28, 2024, we have not recorded any accrual for contingent liabilities associated with the legal proceedings described above based on our belief that liabilities, while possible, are not probable. Further, except as specifically described above, any possible loss or range of loss in these matters cannot be reasonably estimated at this time. We are engaged in legal actions not described above arising in the ordinary course of business and, while there can be no assurance of favorable outcomes, we believe that the ultimate outcome of these actions will not have a material adverse effect on our operating results, liquidity or financial position. |
Income Taxes
Income Taxes | 12 Months Ended |
Jan. 28, 2024 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The income tax expense (benefit) applicable to income before income taxes consists of the following: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) Current income taxes: Federal $ 5,710 $ 1,703 $ 482 State 335 46 42 Foreign 502 228 71 Total current 6,547 1,977 595 Deferred income taxes: Federal (2,499) (2,165) (420) State (206) — — Foreign 216 1 14 Total deferred (2,489) (2,164) (406) Income tax expense (benefit) $ 4,058 $ (187) $ 189 Income before income tax consists of the following: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) U.S. $ 29,495 $ 3,477 $ 8,446 Foreign 4,323 704 1,495 Income before income tax $ 33,818 $ 4,181 $ 9,941 The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income before income taxes as follows: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions, except percentages) Tax expense computed at federal statutory rate $ 7,102 21.0 % $ 878 21.0 % $ 2,088 21.0 % Expense (benefit) resulting from: State income taxes, net of federal tax effect 120 0.4 % 50 1.2 % 42 0.4 % Foreign-derived intangible income (1,408) (4.2) % (739) (17.7) % (520) (5.2) % Stock-based compensation (741) (2.2) % (309) (7.4) % (337) (3.4) % Foreign tax rate differential (467) (1.4) % (83) (2.0) % (497) (5.0) % U.S. federal research and development tax credit (431) (1.3) % (278) (6.6) % (289) (2.9) % Acquisition termination cost — — % 261 6.2 % — — % IP domestication — — % — — % (244) (2.5) % Other (117) (0.3) % 33 0.8 % (54) (0.5) % Income tax expense (benefit) $ 4,058 12.0 % $ (187) (4.5) % $ 189 1.9 % The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below: Jan 28, 2024 Jan 29, 2023 (In millions) Deferred tax assets: Capitalized research and development expenditure $ 3,376 $ 1,859 GILTI deferred tax assets 1,576 800 Accruals and reserves, not currently deductible for tax purposes 1,121 686 Research and other tax credit carryforwards 936 951 Net operating loss and capital loss carryforwards 439 409 Operating lease liabilities 263 193 Stock-based compensation 106 99 Property, equipment and intangible assets 4 66 Other deferred tax assets 179 91 Gross deferred tax assets 8,000 5,154 Less valuation allowance (1,552) (1,484) Total deferred tax assets 6,448 3,670 Deferred tax liabilities: Unremitted earnings of foreign subsidiaries (502) (228) Operating lease assets (255) (179) Acquired intangibles (74) (115) Gross deferred tax liabilities (831) (522) Net deferred tax asset (1) $ 5,617 $ 3,148 (1) Net deferred tax asset includes long-term deferred tax assets of $6.1 billion and $3.4 billion and long-term deferred tax liabilities of $462 million and $247 million for fiscal years 2024 and 2023, respectively. Long-term deferred tax liabilities are included in other long-term liabilities on our Consolidated Balance Sheets. As of January 28, 2024, we intend to indefinitely reinvest approximately $1.1 billion and $250 million of cumulative undistributed earnings held by certain subsidiaries in Israel and the United Kingdom, respectively. We have not provided the amount of unrecognized deferred tax liabilities for temporary differences related to these investments as the determination of such amount is not practicable. As of January 28, 2024 and January 29, 2023, we had a valuation allowance of $1.6 billion and $1.5 billion, respectively, related to capital loss carryforwards, and certain state and other deferred tax assets that management determined are not likely to be realized due, in part, to jurisdictional projections of future taxable income, including capital gains. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as income tax benefits during the period. As of January 28, 2024, we had U.S. federal, state and foreign net operating loss carryforwards of $315 million, $342 million and $361 million, respectively. The federal and state carryforwards will begin to expire in fiscal years 2026 and 2025, respectively. The foreign net operating loss carryforwards of $361 million may be carried forward indefinitely. As of January 28, 2024, we had federal research tax credit carryforwards of $31 million, before the impact of uncertain tax positions, that will begin to expire in fiscal year 2025. We have state research tax credit carryforwards of $1.6 billion, before the impact of uncertain tax positions. $1.5 billion is attributable to the State of California and may be carried over indefinitely and $75 million is attributable to various other states and will begin to expire in fiscal year 2025. As of January 28, 2024, we had federal capital loss carryforwards of $1.4 billion that will begin to expire in fiscal year 2025. Our tax attributes remain subject to audit and may be adjusted for changes or modification in tax laws, other authoritative interpretations thereof, or other facts and circumstances. Utilization of tax attributes may also be subject to limitations due to ownership changes and other limitations provided by the Internal Revenue Code and similar state and foreign tax provisions. If any such limitations apply, the tax attributes may expire or be denied before utilization. A reconciliation of gross unrecognized tax benefits is as follows: Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) Balance at beginning of period $ 1,238 $ 1,013 $ 776 Increases in tax positions for current year 616 268 246 Increases in tax positions for prior years 87 1 14 Decreases in tax positions for prior years (148) (15) (4) Settlements (104) (9) (8) Lapse in statute of limitations (19) (20) (11) Balance at end of period $ 1,670 $ 1,238 $ 1,013 Included in the balance of unrecognized tax benefits as of January 28, 2024 are $1.0 billion of tax benefits that would affect our effective tax rate if recognized. We classify an unrecognized tax benefit as a current liability, or amount refundable, to the extent that we anticipate payment or receipt of cash for income taxes within one year. The amount is classified as a long-term liability, or reduction of long-term amount refundable, if we anticipate payment or receipt of cash for income taxes during a period beyond a year. We include interest and penalties related to unrecognized tax benefits as a component of income tax expense. We recognized net interest and penalties related to unrecognized tax benefits in the income tax expense line of our consolidated statements of income of $42 million, $33 million, and $14 million during fiscal years 2024, 2023 and 2022, respectively. As of January 28, 2024 and January 29, 2023, we have accrued $140 million and $95 million, respectively, for the payment of interest and penalties related to unrecognized tax benefits, which is not included as a component of our gross unrecognized tax benefits. While we believe that we have adequately provided for all tax positions, amounts asserted by tax authorities could be greater or less than our accrued position. Accordingly, our provisions on federal, state and foreign tax-related matters to be recorded in the future may change as revised estimates are made or the underlying matters are settled or otherwise resolved. As of January 28, 2024, we have not identified any positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within the next twelve months. We are subject to taxation by taxing authorities both in the United States and other countries. As of January 28, 2024, the significant tax jurisdictions that may be subject to examination include the United States for fiscal years after 2020, as well as China, Germany, Hong Kong, India, Israel, Taiwan, and the United Kingdom for fiscal years 2005 through 2023. As of January 28, 2024, the significant tax jurisdictions for which we are currently under examination include Germany, India, Israel, and Taiwan for fiscal years 2005 through 2023. |
Shareholders_ Equity
Shareholders’ Equity | 12 Months Ended |
Jan. 28, 2024 | |
Equity [Abstract] | |
Shareholders’ Equity | Shareholders’ Equity Capital Return Program In August 2023, our Board of Directors approved an increase to our share repurchase program of an additional $25.0 billion, without expiration. During fiscal year 2024, we repurchased 21 million shares of our common stock for $9.7 billion. As of January 28, 2024, we were authorized, subject to certain specifications, to repurchase additional shares of our common stock up to $22.5 billion. From January 29, 2024 through February 16, 2024, we repurchased 2.8 million shares for $1.9 billion pursuant to a Rule 10b5-1 trading plan. Our share repurchase program aims to offset dilution from shares issued to employees. We may pursue additional share repurchases as we weigh market factors and other investment opportunities. During fiscal years 2024, 2023, and 2022, we paid $395 million, $398 million, and $399 million in cash dividends to our shareholders, respectively. Our cash dividend program and the payment of future cash dividends under that program are subject to our Board of Directors' continuing determination that the dividend program and the declaration of dividends thereunder are in the best interests of our shareholders. In fiscal year 2022, we retired our existing 349 million treasury shares. These shares assumed the status of authorized and unissued shares upon retirement. The excess of repurchase price over par value was allocated between additional paid-in capital and retained earnings, resulting in a reduction in additional paid-in capital by $20 million and retained earnings by $12.0 billion. Any future repurchased shares will assume the status of authorized and unissued shares. |
Employee Retirement Plans
Employee Retirement Plans | 12 Months Ended |
Jan. 28, 2024 | |
Retirement Benefits [Abstract] | |
Employee Retirement Plans | Employee Retirement Plans We provide tax-qualified defined contribution plans to eligible employees in the U.S. and certain other countries. Our contribution expense for fiscal years 2024, 2023, and 2022 was $255 million, $227 million, and $168 million, respectively. |
Segment Information
Segment Information | 12 Months Ended |
Jan. 28, 2024 | |
Segment Reporting [Abstract] | |
Segment Information | Segment Information Our Chief Executive Officer, who is considered to be our chief operating decision maker, or CODM, reviews financial information presented on an operating segment basis for purposes of making decisions and assessing financial performance. The Compute & Networking segment includes our Data Center accelerated computing platform; networking; automotive artificial intelligence, or AI, Cockpit, autonomous driving development agreements, and autonomous vehicle solutions; electric vehicle computing platforms; Jetson for robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse Enterprise software for building and operating 3D internet applications. Operating results by segment include costs or expenses that are directly attributable to each segment, and costs or expenses that are leveraged across our unified architecture and therefore allocated between our two segments. The “All Other” category includes the expenses that our CODM does not assign to either Compute & Networking or Graphics for purposes of making operating decisions or assessing financial performance. The expenses include stock-based compensation expense, corporate infrastructure and support costs, acquisition-related and other costs, intellectual property related, or IP-related costs, acquisition termination cost, and other non-recurring charges and benefits that our CODM deems to be enterprise in nature. Our CODM does not review any information regarding total assets on a reportable segment basis. Depreciation and amortization expense directly attributable to each reportable segment is included in operating results for each segment. However, our CODM does not evaluate depreciation and amortization expense by operating segment and, therefore, it is not separately presented. There is no intersegment revenue. The accounting policies for segment reporting are the same as for our consolidated financial statements. The table below presents details of our reportable segments and the “All Other” category. Compute & Networking Graphics All Other Consolidated (In millions) Year Ended Jan 28, 2024: Revenue $ 47,405 $ 13,517 $ — $ 60,922 Operating income (loss) $ 32,016 $ 5,846 $ (4,890) $ 32,972 Year Ended Jan 29, 2023: Revenue $ 15,068 $ 11,906 $ — $ 26,974 Operating income (loss) $ 5,083 $ 4,552 $ (5,411) $ 4,224 Year Ended Jan 30, 2022: Revenue $ 11,046 $ 15,868 $ — $ 26,914 Operating income (loss) $ 4,598 $ 8,492 $ (3,049) $ 10,041 Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) Reconciling items included in "All Other" category: Stock-based compensation expense $ (3,549) $ (2,710) $ (2,004) Unallocated cost of revenue and operating expenses (728) (595) (399) Acquisition-related and other costs (583) (674) (636) IP-related and legal settlement costs (40) (23) (10) Restructuring costs and other — (54) — Acquisition termination cost — (1,353) — Other 10 (2) — Total $ (4,890) $ (5,411) $ (3,049) Revenue by geographic areas is designated based upon the billing location of the customer. End customer location may be different than our customer’s billing location. Revenue by geographic areas was as follows: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 Revenue: (In millions) United States $ 26,966 $ 8,292 $ 4,349 Taiwan 13,405 6,986 8,544 China (including Hong Kong) 10,306 5,785 7,111 Other countries 10,245 5,911 6,910 Total revenue $ 60,922 $ 26,974 $ 26,914 Revenue from sales to customers outside of the United States accounted for 56%, 69%, and 84% of total revenue for fiscal years 2024, 2023, and 2022, respectively. The increase in revenue to the United States for fiscal year 2024 was primarily due to higher U.S.-based Compute & Networking segment demand. Sales to one customer represented 13% of total revenue for fiscal year 2024, which was attributable to the Compute & Networking segment. No customer represented 10% or more of total revenue for fiscal years 2023 and 2022. The following table summarizes information pertaining to our revenue by each of the specialized markets we serve: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 Revenue: (In millions) Data Center $ 47,525 $ 15,005 $ 10,613 Gaming 10,447 9,067 12,462 Professional Visualization 1,553 1,544 2,111 Automotive 1,091 903 566 OEM and Other 306 455 1,162 Total revenue $ 60,922 $ 26,974 $ 26,914 The following table presents summarized information for long-lived assets by country. Long-lived assets consist of property and equipment and exclude other assets, operating lease assets, goodwill, and intangible assets. Jan 28, 2024 Jan 29, 2023 Long-lived assets: (In millions) United States $ 2,595 $ 2,587 Taiwan 773 702 Israel 325 283 Other countries 221 235 Total long-lived assets $ 3,914 $ 3,807 |
Schedule II - Valuation and Qua
Schedule II - Valuation and Qualifying Accounts | 12 Months Ended |
Jan. 28, 2024 | |
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] | |
Schedule II - Valuation and Qualifying Accounts | Schedule II – Valuation and Qualifying Accounts Description Balance at Additions Deductions Balance at (In millions) Fiscal year 2024 Allowance for doubtful accounts $ 4 $ — (1) $ — (1) $ 4 Sales return allowance $ 26 $ 213 (2) $ (130) (4) $ 109 Deferred tax valuation allowance $ 1,484 $ 162 (3) $ (94) (3) $ 1,552 Fiscal year 2023 Allowance for doubtful accounts $ 4 $ — (1) $ — (1) $ 4 Sales return allowance $ 13 $ 104 (2) $ (91) (4) $ 26 Deferred tax valuation allowance $ 907 $ 577 (3) $ — $ 1,484 Fiscal year 2022 Allowance for doubtful accounts $ 4 $ — (1) $ — (1) $ 4 Sales return allowance $ 17 $ 19 (2) $ (23) (4) $ 13 Deferred tax valuation allowance $ 728 $ 179 (3) $ — $ 907 (1) Additions represent either expense or acquired balances and deductions represent write-offs. (2) Additions represent estimated product returns charged as a reduction to revenue or an acquired balance. (3) Additional valuation allowance on deferred tax assets not likely to be realized. Additions represent additional valuation allowance on capital loss carryforwards, and certain state and other deferred tax assets. Deductions represent the release of valuation allowance on certain state deferred tax assets. Refer to Note 14 of the Notes to the Consolidated Financial Statements in Part IV, Item 15 of this Annual Report on Form 10-K for additional information. (4) Represents sales returns. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Pay vs Performance Disclosure | |||
Net income | $ 29,760 | $ 4,368 | $ 9,752 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended | 12 Months Ended |
Jan. 28, 2024 shares | Jan. 28, 2024 shares | |
Trading Arrangements, by Individual | ||
Material Terms of Trading Arrangement | On December 18, 2023, John O. Dabiri, a member of our Board of Directors, adopted a trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) for the sale through December 2, 2024 of an estimated 553 shares of our common stock, assuming our closing stock price as of January 26, 2024. The number of shares is based on an estimate because the plan specifies a formulaic dollar amount of shares to be sold. | |
Non-Rule 10b5-1 Arrangement Adopted | false | |
Rule 10b5-1 Arrangement Terminated | false | |
Non-Rule 10b5-1 Arrangement Terminated | false | |
John O. Dabiri [Member] | ||
Trading Arrangements, by Individual | ||
Name | John O. Dabiri | |
Title | Director | |
Rule 10b5-1 Arrangement Adopted | true | |
Adoption Date | December 18, 2023 | |
Arrangement Duration | 350 days | |
Aggregate Available | 553 | 553 |
Organization and Summary of S_2
Organization and Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Jan. 28, 2024 | |
Accounting Policies [Abstract] | |
Our Company | Our Company Headquartered in Santa Clara, California, NVIDIA was incorporated in California in April 1993 and reincorporated in Delaware in April 1998. All references to “NVIDIA,” “we,” “us,” “our” or the “Company” mean NVIDIA Corporation and its subsidiaries. |
Fiscal Year | Fiscal Year We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal years 2024, 2023 and 2022 were all 52-week years. |
Principles of Consolidation | Principles of Consolidation Our consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, cash equivalents and marketable securities, accounts receivable, inventories and product purchase commitments, income taxes, goodwill, stock-based compensation, litigation, investigation and settlement costs, restructuring and other charges, property, plant, and equipment, and other contingencies. These estimates are based on historical facts and various other assumptions that we believe are reasonable. In February 2023, we assessed the useful lives of our property, plant, and equipment. Based on advances in technology and usage rate, we increased the estimated useful life of most of our server, storage, and network equipment from three four five |
Revenue Recognition | Revenue Recognition We derive our revenue from product sales, including hardware and systems, license and development arrangements, software licensing, and cloud services. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract (where revenue is allocated on a relative standalone selling price basis by maximizing the use of observable inputs to determine the standalone selling price for each performance obligation); and (5) recognition of revenue when, or as, we satisfy a performance obligation. Product Sales Revenue Revenue from product sales is recognized upon transfer of control of products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. Certain products are sold with support or an extended warranty for the incorporated system, hardware, and/or software. Support and extended warranty revenue are recognized ratably over the service period, or as services are performed. Revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers. For products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. However, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to accurately reflect our estimated exposure for product returns. Our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and marketing development funds, or MDFs, which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners’ activities while also promoting NVIDIA products. We account for customer programs as a reduction to revenue and accrue for such programs for potential rebates and MDFs based on the amount we expect to be claimed by customers. License and Development Arrangements Our license and development arrangements with customers typically require significant customization of our IP components. As a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. We measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. If a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period. Software Licensing Our software licenses provide our customers with a right to use the software when it is made available to the customer. Customers may purchase either perpetual licenses or subscriptions to licenses, which differ mainly in the duration over which the customer benefits from the software. Software licenses are frequently sold along with the right to receive, on a when-and-if available basis, future unspecified software updates and upgrades. Revenue from software licenses is recognized up front when the software is made available to the customer. Software support revenue is recognized ratably over the service period, or as services are performed. Cloud Services Cloud services, which allow customers to use hosted software and hardware infrastructure without taking possession of the software or hardware, are provided on a subscription basis or a combination of subscription plus usage. Revenue related to subscription-based cloud services is recognized ratably over the contract period. Revenue related to cloud services based on usage is recognized as usage occurs. Cloud services are typically sold on a standalone basis, but certain offerings may be sold with hardware and/or software and related support. Contracts with Multiple Performance Obligations Our contracts may contain more than one of the products and services listed above, each of which is separately accounted for as a distinct performance obligation. We account for multiple agreements with a single customer as a single contract if the contractual terms and/or substance of those agreements indicate that they may be so closely related that they are, in effect, parts of a single contract. We allocate the total transaction price to each distinct performance obligation in a multiple performance obligations arrangement on a relative standalone selling price basis. The standalone selling price reflects the price we would charge for a specific product or service if it were sold separately in similar circumstances and to similar customers. When determining standalone selling price, we maximize the use of observable inputs. If a contract contains a single performance obligation, no allocation is required. |
Product Warranties | Product Warranties We offer a limited warranty to end-users ranging from one |
Stock-based Compensation | Stock-based Compensation We use the closing trading price of our common stock on the date of grant, minus a dividend yield discount, as the fair value of awards of restricted stock units, or RSUs, and performance stock units that are based on our corporate financial performance targets, or PSUs. We use a Monte Carlo simulation on the date of grant to estimate the fair value of performance stock units that are based on market conditions, or market-based PSUs. The compensation expense for RSUs and market-based PSUs is recognized using a straight-line attribution method over the requisite employee service period while compensation expense for PSUs is recognized using an accelerated amortization model. We estimate the fair value of shares to be issued under our employee stock purchase plan, or ESPP, using the Black-Scholes model at the commencement of an offering period in March and September of each year. Stock-based compensation for our ESPP is expensed using an accelerated amortization model. Additionally, for RSU, PSU, and market-based PSU awards, we estimate forfeitures semi-annually and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates. Forfeitures are estimated based on historical experience. |
Litigation, Investigation and Settlement Costs | Litigation, Investigation and Settlement Costs We currently, are, and will likely continue to be subject to claims, litigation, and other actions, including potential regulatory proceedings, involving patent and other intellectual property matters, taxes, labor and employment, competition and antitrust, commercial disputes, goods and services offered by us and by third parties, and other matters. There are many uncertainties associated with any litigation or investigation, and we cannot be certain that these actions or other third-party claims against us will be resolved without litigation, fines and/or substantial settlement payments or judgments. If information becomes available that causes us to determine that a loss in any of our pending litigation, investigations or settlements is probable, and we can reasonably estimate the loss associated with such events, we will record the loss in accordance with U.S. GAAP. However, the actual liability in any such litigation or investigation may be materially different from our estimates, which could require us to record additional costs. |
Foreign Currency Remeasurement | Foreign Currency Remeasurement We use the U.S. dollar as our functional currency for our subsidiaries. Foreign currency monetary assets and liabilities are remeasured into United States dollars at end-of-period exchange rates. Non-monetary assets and liabilities such as property and equipment and equity are remeasured at historical exchange rates. Revenue and expenses are remeasured at exchange rates in effect during each period, except for those expenses related to non-monetary balance sheet amounts, which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in earnings in our Consolidated Statements of Income and to date have not been significant. |
Income Taxes | Income Taxes We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized. Our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. Our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the U.S., or foreign jurisdictions where we operate, or changes in other facts or circumstances. In addition, we recognize liabilities for potential U.S. and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. If we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly. As of January 28, 2024, we had a valuation allowance of $1.6 billion related to capital loss carryforwards, and certain state and other deferred tax assets that management determined are not likely to be realized due, in part, to jurisdictional projections of future taxable income, including capital gains. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as income tax benefits during the period. We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense. |
Net Income Per Share | Net Income Per Share Basic net income per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common and potentially dilutive shares outstanding during the period, using the treasury stock method. Any anti-dilutive effect of equity awards outstanding is not included in the computation of diluted net income per share. |
Cash and Cash Equivalents and Marketable Securities | Cash and Cash Equivalents and Marketable Securities We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We currently classify our investments as current based on the nature of the investments and their availability for use in current operations. We classify our cash equivalents and marketable securities related to debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income (expense), net, section of our Consolidated Statements of Income. Available-for-sale debt investments are subject to a periodic impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or we intend to sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the other income (expense), net section of our Consolidated Statements of Income. |
Cash and Cash Equivalents and Marketable Securities | Cash and Cash Equivalents and Marketable Securities We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We currently classify our investments as current based on the nature of the investments and their availability for use in current operations. We classify our cash equivalents and marketable securities related to debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income (expense), net, section of our Consolidated Statements of Income. Available-for-sale debt investments are subject to a periodic impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or we intend to sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the other income (expense), net section of our Consolidated Statements of Income. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The carrying value of cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their relatively short maturities as of January 28, 2024 and January 29, 2023. Marketable securities are comprised of available-for-sale securities that are reported at fair value with the related unrealized gains or losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. Fair value of the marketable securities is determined based on quoted market prices. Derivative instruments are recognized as either assets or liabilities and are measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. For derivative instruments designated as fair value hedges, the gains or losses are recognized in earnings in the periods of change together with the offsetting losses or gains on the hedged items attributed to the risk being hedged. For derivative instruments designated as cash-flow hedges, the effective portion of the gains or losses on the derivatives is initially reported as a component of other comprehensive income or loss and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments not designated for hedge accounting, changes in fair value are recognized in earnings. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, marketable securities, and accounts receivable. Our investment policy requires the purchase of highly-rated fixed income securities, the diversification of investment type and credit exposures, and includes certain limits on our portfolio duration. We perform ongoing credit evaluations of our customers’ financial condition and maintain an allowance for potential credit losses. This allowance consists of an amount identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance and letters of credit. |
Inventories | Inventories Inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. Inventory costs consist primarily of the cost of semiconductors, including wafer fabrication, assembly, testing and packaging, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, and shipping costs, as well as the cost of purchased memory products and other component parts. We charge cost of sales for inventory provisions to write-down our inventory to the lower of cost or net realizable value or for obsolete or excess inventory, and for excess product purchase commitments. Most of our inventory provisions relate to excess quantities of products, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and market conditions. Once inventory has been written-off or written-down, it creates a new cost basis for the inventory that is not subsequently written-up. We record a liability for noncancelable purchase commitments with suppliers for quantities in excess of our future demand forecasts consistent with our valuation of obsolete or excess inventory. |
Property and Equipment | Property and Equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method based on the estimated useful lives of the assets of three |
Leases | Leases We determine if an arrangement is or contains a lease at inception. Operating leases with lease terms of more than 12 months are included in operating lease assets, accrued and other current liabilities, and long-term operating lease liabilities on our consolidated balance sheet. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term. Operating lease assets and liabilities are recognized based on the present value of the remaining lease payments discounted using our incremental borrowing rate. Operating lease assets also include initial direct costs incurred and prepaid lease payments, minus any lease incentives. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense is recognized on a straight-line basis over the lease term. We combine the lease and non-lease components in determining the operating lease assets and liabilities. |
Goodwill | Goodwill Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier if indicators of potential impairment exist. In completing our impairment test, we perform either a qualitative or a quantitative analysis on a reporting unit basis. Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting units. |
Intangible Assets and Other Long-Lived Assets | Intangible Assets and Other Long-Lived Assets Intangible assets primarily represent acquired intangible assets including developed technology and customer relationships, as well as rights acquired under technology licenses, patents, and acquired IP. We currently amortize our intangible assets with finite lives over periods ranging from one Long-lived assets, such as property and equipment and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. The recoverability of assets or asset groups to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the estimated fair value of the asset or asset group. Fair value is determined based on the estimated discounted future cash flows expected to be generated by the asset or asset group. Assets and liabilities to be disposed of would be separately presented in the Consolidated Balance Sheet and the assets would be reported at the lower of the carrying amount or fair value less costs to sell, and would no longer be depreciated. |
Business Combination | Business Combination We allocate the fair value of the purchase price of an acquisition to the tangible assets acquired, liabilities assumed, and intangible assets acquired, based on their estimated fair values. The excess of the fair value of the purchase price over the fair values of these net tangible and intangible assets acquired is recorded as goodwill. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but our estimates and assumptions are inherently uncertain and subject to refinement. The estimates and assumptions used in valuing intangible assets include, but are not limited to, the amount and timing of projected future cash flows, discount rate used to determine the present value of these cash flows and asset lives. These estimates are inherently uncertain and, therefore, actual results may differ from the estimates made. As a result, during the measurement period of up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the measurement period's conclusion or final determination of the fair value of the purchase price of an acquisition, whichever comes first, any subsequent adjustments are recorded to our Consolidated Statements of Income. Acquisition-related expenses are recognized separately from the business combination and expensed as incurred. |
Investment in Non-Affiliated Entities | Investments in Non-Affiliated Entities Our investment in non-affiliates consists of marketable equity securities, which are publicly traded, and non-marketable equity securities, which are investments in privately held companies. Marketable equity securities have readily determinable fair values with changes in fair value recorded in other income (expense), net. Non-marketable equity securities include investments that do not have a readily determinable fair value. The investments that do not have readily determinable fair value are measured at cost minus impairment, if any, and are adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment in the same issuer, or the measurement alternative. Fair value is based upon observable inputs in an inactive market and the valuation requires our judgment due to the absence of market prices and inherent lack of liquidity. All gains and losses on these investments, realized and unrealized, are recognized in other income (expense), net on our Consolidated Statements of Income. We assess whether an impairment loss has occurred on our investments in non-marketable equity securities, accounted for under the measurement alternative based on quantitative and qualitative factors. If any impairment is identified for non-marketable equity securities, we write down the investment to its fair value and record the corresponding charge through other income (expense), net on our Consolidated Statements of Income. |
Recently Issued Accounting Pronouncements | Recently Issued Accounting Pronouncements Recent Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board, or FASB, issued a new accounting standard to provide for additional disclosures about significant expenses in operating segments. The standard is effective for our annual reporting for fiscal year 2025 and for interim period reporting starting in fiscal year 2026 retrospectively. We are currently evaluating the impact of this standard on our Consolidated Financial Statements. In December 2023, the FASB issued a new accounting standard which provides for new and changes to income tax disclosures including disaggregation of the rate reconciliation and income taxes paid disclosures. The amendments in the standard are effective for annual periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively, with retrospective application permitted. We expect to adopt this standard in our annual period beginning fiscal year 2026. We are currently evaluating the impact of this standard on our Consolidated Financial Statements. |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Jan. 28, 2024 | |
Leases [Abstract] | |
Schedule of Future Minimum Lease Payments | Future minimum lease payments under our non-cancelable operating leases as of January 28, 2024, are as follows: Operating Lease Obligations (In millions) Fiscal Year: 2025 $ 290 2026 270 2027 253 2028 236 2029 202 2030 and thereafter 288 Total 1,539 Less imputed interest 192 Present value of net future minimum lease payments 1,347 Less short-term operating lease liabilities 228 Long-term operating lease liabilities $ 1,119 |
Schedule of Other Information Related to Leases | Other information related to leases was as follows: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) Supplemental cash flows information Operating cash flows used for operating leases $ 286 $ 184 $ 154 Operating lease assets obtained in exchange for lease obligations $ 531 $ 358 $ 266 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 12 Months Ended |
Jan. 28, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of Stock-Based Compensation Expense, Net of Amounts Capitalized as Inventory | Our Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) Cost of revenue $ 141 $ 138 $ 141 Research and development 2,532 1,892 1,298 Sales, general and administrative 876 680 565 Total $ 3,549 $ 2,710 $ 2,004 |
Schedule of Equity Awards | The following is a summary of equity awards granted under our equity incentive plans: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions, except per share data) RSUs, PSUs and Market-based PSUs Awards granted 14 25 18 Estimated total grant-date fair value $ 5,316 $ 4,505 $ 3,492 Weighted average grant-date fair value per share $ 374.08 $ 183.72 $ 190.69 ESPP Shares purchased 3 3 5 Weighted average price per share $ 158.07 $ 122.54 $ 56.36 Weighted average grant-date fair value per share $ 69.90 $ 51.87 $ 23.24 |
Schedule of ESPP Valuation Assumptions | The fair value of shares issued under our ESPP have been estimated with the following assumptions: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (Using the Black-Scholes model) ESPP Weighted average expected life (in years) 0.1-2.0 0.1-2.0 0.1-2.0 Risk-free interest rate 3.9%-5.5% —%-4.6% —%-0.5% Volatility 31%-67% 43%-72% 20%-58% Dividend yield 0.1% 0.1% 0.1% |
Schedule of Equity Award Transactions | The following is a summary of our equity award transactions under our equity incentive plans: RSUs, PSUs and Market-based PSUs Outstanding Number of Shares Weighted Average Grant-Date Fair Value (In millions, except per share data) Balances, Jan 29, 2023 45 $ 158.45 Granted 14 $ 374.08 Vested restricted stock (21) $ 148.56 Canceled and forfeited (1) $ 206.35 Balances, Jan 28, 2024 37 $ 245.94 Vested and expected to vest after Jan 28, 2024 37 $ 245.49 |
Net Income Per Share (Tables)
Net Income Per Share (Tables) | 12 Months Ended |
Jan. 28, 2024 | |
Earnings Per Share [Abstract] | |
Schedule of Reconciliation of Numerators and Denominators of Basic and Diluted net Income Per Share Computations | The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions, except per share data) Numerator: Net income $ 29,760 $ 4,368 $ 9,752 Denominator: Basic weighted average shares 2,469 2,487 2,496 Dilutive impact of outstanding equity awards 25 20 39 Diluted weighted average shares 2,494 2,507 2,535 Net income per share: Basic (1) $ 12.05 $ 1.76 $ 3.91 Diluted (2) $ 11.93 $ 1.74 $ 3.85 Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive 15 40 21 (1) Calculated as net income divided by basic weighted average shares. (2) Calculated as net income divided by diluted weighted average shares. |
Amortizable Intangible Assets (
Amortizable Intangible Assets (Tables) | 12 Months Ended |
Jan. 28, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of the Components of Our Amortizable Intangible Assets | The components of our amortizable intangible assets are as follows: Jan 28, 2024 Jan 29, 2023 Gross Carrying Amount Accumulated Net Gross Carrying Amount Accumulated Net (In millions) Acquisition-related intangible assets (1) $ 2,642 $ (1,720) $ 922 $ 3,093 $ (1,614) $ 1,479 Patents and licensed technology 449 (259) 190 446 (249) 197 Total intangible assets $ 3,091 $ (1,979) $ 1,112 $ 3,539 $ (1,863) $ 1,676 (1) During the first quarter of fiscal year 2023, we commenced amortization of a $630 million in-process research and development intangible asset related to our acquisition of Mellanox. |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense | The following table outlines the estimated future amortization expense related to the net carrying amount of intangible assets as of January 28, 2024: Future Amortization Expense (In millions) Fiscal Year: 2025 $ 555 2026 261 2027 150 2028 37 2029 9 2030 and thereafter 100 Total $ 1,112 |
Cash Equivalents and Marketab_2
Cash Equivalents and Marketable Securities (Tables) | 12 Months Ended |
Jan. 28, 2024 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of Cash Equivalents and Marketable Securities | The following is a summary of cash equivalents and marketable securities: Jan 28, 2024 Amortized Unrealized Unrealized Estimated Reported as Cash Equivalents Marketable Securities (In millions) Corporate debt securities $ 10,126 $ 31 $ (5) $ 10,152 $ 2,231 $ 7,921 Debt securities issued by the U.S. Treasury 9,517 17 (10) 9,524 1,315 8,209 Debt securities issued by U.S. government agencies 2,326 8 (1) 2,333 89 2,244 Money market funds 3,031 — — 3,031 3,031 — Certificates of deposit 510 — — 510 294 216 Foreign government bonds 174 — — 174 60 114 Total $ 25,684 $ 56 $ (16) $ 25,724 $ 7,020 $ 18,704 Jan 29, 2023 Amortized Unrealized Unrealized Estimated Reported as Cash Equivalents Marketable Securities (In millions) Corporate debt securities $ 4,809 $ — $ (12) $ 4,797 $ 1,087 $ 3,710 Debt securities issued by the U.S. Treasury 4,185 1 (44) 4,142 — 4,142 Debt securities issued by U.S. government agencies 1,836 — (2) 1,834 50 1,784 Money market funds 1,777 — — 1,777 1,777 — Certificates of deposit 365 — — 365 134 231 Foreign government bonds 140 — — 140 100 40 Total $ 13,112 $ 1 $ (58) $ 13,055 $ 3,148 $ 9,907 The amortized cost and estimated fair value of cash equivalents and marketable securities are shown below by contractual maturity. Jan 28, 2024 Jan 29, 2023 Amortized Estimated Amortized Estimated (In millions) Less than one year $ 16,336 $ 16,329 $ 9,738 $ 9,708 Due in 1 - 5 years 9,348 9,395 3,374 3,347 Total $ 25,684 $ 25,724 $ 13,112 $ 13,055 |
Schedule of Marketable Securities in a Continuous Unrealized Loss Position | The following tables provide the breakdown of unrealized losses, aggregated by investment category and length of time that individual securities have been in a continuous loss position: Jan 28, 2024 Less than 12 Months 12 Months or Greater Total Estimated Fair Value Gross Unrealized Loss Estimated Fair Value Gross Unrealized Loss Estimated Fair Value Gross Unrealized Loss (In millions) Debt securities issued by the U.S. Treasury $ 3,343 $ (5) $ 1,078 $ (5) $ 4,421 $ (10) Corporate debt securities 1,306 (3) 618 (2) 1,924 (5) Debt securities issued by U.S. government agencies 670 (1) — — 670 (1) Total $ 5,319 $ (9) $ 1,696 $ (7) $ 7,015 $ (16) Jan 29, 2023 Less than 12 Months 12 Months or Greater Total Estimated Fair Value Gross Unrealized Loss Estimated Fair Value Gross Unrealized Loss Estimated Fair Value Gross Unrealized Loss (In millions) Debt securities issued by the U.S. Treasury $ 2,444 $ (21) $ 1,172 $ (23) $ 3,616 $ (44) Corporate debt securities 1,188 (7) 696 (5) 1,884 (12) Debt securities issued by U.S. government agencies 1,307 (2) — — 1,307 (2) Total $ 4,939 $ (30) $ 1,868 $ (28) $ 6,807 $ (58) |
Fair Value of Financial Asset_2
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities (Tables) | 12 Months Ended |
Jan. 28, 2024 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value of Financial Assets and Liabilities | Fair Value at Pricing Category Jan 28, 2024 Jan 29, 2023 (In millions) Assets Cash equivalents and marketable securities: Money market funds Level 1 $ 3,031 $ 1,777 Corporate debt securities Level 2 $ 10,152 $ 4,797 Debt securities issued by the U.S. Treasury Level 2 $ 9,524 $ 4,142 Debt securities issued by U.S. government agencies Level 2 $ 2,333 $ 1,834 Certificates of deposit Level 2 $ 510 $ 365 Foreign government bonds Level 2 $ 174 $ 140 Other assets (Investment in non-affiliated entities): Publicly-held equity securities Level 1 $ 225 $ 11 Liabilities (1) 0.309% Notes Due 2023 Level 2 $ — $ 1,230 0.584% Notes Due 2024 Level 2 $ 1,228 $ 1,185 3.20% Notes Due 2026 Level 2 $ 970 $ 966 1.55% Notes Due 2028 Level 2 $ 1,115 $ 1,099 2.85% Notes Due 2030 Level 2 $ 1,367 $ 1,364 2.00% Notes Due 2031 Level 2 $ 1,057 $ 1,044 3.50% Notes Due 2040 Level 2 $ 851 $ 870 3.50% Notes Due 2050 Level 2 $ 1,604 $ 1,637 3.70% Notes Due 2060 Level 2 $ 403 $ 410 (1) These liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs. |
Equity Securities without Readily Determinable Fair Value | Adjustments to the carrying value of our non-marketable equity securities accounted for under the measurement alternative were as follows: Year Ended Jan 28, 2024 (In millions) Carrying amount as of Jan 29, 2023 $ 288 Adjustments related to non-marketable equity securities: Net additions 859 Unrealized gains 194 Impairments and unrealized losses (20) Carrying amount as of Jan 28, 2024 $ 1,321 The following table summarizes the cumulative gross unrealized gains and cumulative gross unrealized losses and impairments related to non-marketable equity securities accounted for under the measurement alternative: Jan 28, 2024 (In millions) Cumulative gross unrealized gains $ 270 Cumulative gross unrealized losses and impairments (45) |
Balance Sheet Components (Table
Balance Sheet Components (Tables) | 12 Months Ended |
Jan. 28, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of Inventory | Certain balance sheet components are as follows: Jan 28, 2024 Jan 29, 2023 (In millions) Inventories (1) : Raw materials $ 1,719 $ 2,430 Work in-process 1,505 466 Finished goods 2,058 2,263 Total inventories $ 5,282 $ 5,159 (1) In fiscal years 2024 and 2023, we recorded an inventory provision of $774 million and $1.0 billion, respectively, in cost of revenue. |
Schedule of Property and Equipment | Jan 28, 2024 Jan 29, 2023 Estimated (In millions) (In years) Property and Equipment: Land $ 218 $ 218 (A) Buildings, leasehold improvements, and furniture 1,816 1,598 (B) Equipment, compute hardware, and software 5,200 4,303 3-7 Construction in process 189 382 (C) Total property and equipment, gross 7,423 6,501 Accumulated depreciation and amortization (3,509) (2,694) Total property and equipment, net $ 3,914 $ 3,807 (A) Land is a non-depreciable asset. (B) The estimated useful lives of our buildings are up to thirty years. Leasehold improvements and finance leases are amortized based on the lesser of either the asset’s estimated useful life or the expected remaining lease term. (C) Construction in process represents assets that are not available for their intended use as of the balance sheet date. |
Schedule of Other Assets | Jan 28, 2024 Jan 29, 2023 Other assets: (In millions) Prepaid supply and capacity agreements (1) $ 2,458 $ 2,989 Investments in non-affiliated entities 1,546 299 Prepaid royalties 364 387 Other 132 145 Total other assets $ 4,500 $ 3,820 (1) As of January 28, 2024 and January 29, 2023, there was an additional $2.5 billion and $458 million of short-term prepaid supply and capacity agreements included in Prepaid expenses and other current assets, respectively. |
Schedule of Accrued and Other Current Liabilities | Jan 28, 2024 Jan 29, 2023 (In millions) Accrued and Other Current Liabilities: Customer program accruals $ 2,081 $ 1,196 Excess inventory purchase obligations (1) 1,655 954 Deferred revenue (2) 764 354 Accrued payroll and related expenses 675 530 Product warranty and return provisions 415 108 Taxes payable 296 467 Operating leases 228 176 Unsettled share repurchases 187 117 Licenses and royalties 182 149 Other 199 69 Total accrued and other current liabilities $ 6,682 $ 4,120 (1) In fiscal years 2024 and 2023, we recorded an expense of approximately $1.4 billion and $1.1 billion, respectively, in cost of revenue for inventory purchase obligations in excess of our current demand projections, supplier charges and for penalties related to cancellations and underutilization. (2) Deferred revenue primarily includes customer advances and deferrals related to support for hardware and software, license and development arrangements, and cloud services. $233 million and $35 million of the balance in fiscal 2024 and 2023 respectively, related to customer advances. |
Schedule of Other Long-term Liabilities | Jan 28, 2024 Jan 29, 2023 (In millions) Other Long-Term Liabilities: Income tax payable (1) $ 1,361 $ 1,204 Deferred income tax 462 247 Deferred revenue (2) 573 218 Licenses payable 80 181 Other 65 63 Total other long-term liabilities $ 2,541 $ 1,913 (1) Income tax payable is comprised of the long-term portion of the one-time transition tax payable, unrecognized tax benefits, and related interest and penalties. (2) Deferred revenue primarily includes deferrals related to support for hardware and software. |
Schedule of Changes in Deferred Revenue | The following table shows the changes in deferred revenue during fiscal years 2024 and 2023. Jan 28, 2024 Jan 29, 2023 (In millions) Balance at beginning of period $ 572 $ 502 Deferred revenue additions during the period 2,038 830 Revenue recognized during the period (1,273) (760) Balance at end of period $ 1,337 $ 572 |
Derivative Financial Instrume_2
Derivative Financial Instruments (Tables) | 12 Months Ended |
Jan. 28, 2024 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Notional Value of Our Foreign Currency Forward Contracts Outstanding | The table below presents the notional value of our foreign currency forward contracts outstanding: Jan 28, 2024 Jan 29, 2023 (In millions) Designated as cash flow hedges $ 1,168 $ 1,128 Non-designated hedges $ 597 $ 366 |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Jan. 28, 2024 | |
Debt Disclosure [Abstract] | |
Schedule of Long-term Debt | The carrying value of our outstanding notes, the calendar year of maturity, and the associated interest rates were as follows: Expected Effective Jan 28, 2024 Jan 29, 2023 (In millions) 0.309% Notes Due 2023 (1) — 0.41% $ — $ 1,250 0.584% Notes Due 2024 0.4 0.66% 1,250 1,250 3.20% Notes Due 2026 2.6 3.31% 1,000 1,000 1.55% Notes Due 2028 4.4 1.64% 1,250 1,250 2.85% Notes Due 2030 6.2 2.93% 1,500 1,500 2.00% Notes Due 2031 7.4 2.09% 1,250 1,250 3.50% Notes Due 2040 16.2 3.54% 1,000 1,000 3.50% Notes Due 2050 26.2 3.54% 2,000 2,000 3.70% Notes Due 2060 36.2 3.73% 500 500 Unamortized debt discount and issuance costs (41) (47) Net carrying amount 9,709 10,953 Less short-term portion (1,250) (1,250) Total long-term portion $ 8,459 $ 9,703 (1) In fiscal year 2024, we repaid the 0.309% Notes Due 2023. |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Jan. 28, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Purchase Obligation, Fiscal Year Maturity | Total future purchase commitments as of January 28, 2024 are as follows: Commitments (In millions) Fiscal Year: 2025 $ 17,316 2026 1,143 2027 1,060 2028 770 2029 and thereafter 418 Total $ 20,707 |
Schedule of Product Warranty Activity | The estimated product returns and estimated product warranty activity consisted of the following: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) Balance at beginning of period $ 82 $ 46 $ 22 Additions 278 145 40 Utilization (54) (109) (16) Balance at end of period $ 306 $ 82 $ 46 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Jan. 28, 2024 | |
Income Tax Disclosure [Abstract] | |
Schedule of Income Tax Expense (benefit) | The income tax expense (benefit) applicable to income before income taxes consists of the following: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) Current income taxes: Federal $ 5,710 $ 1,703 $ 482 State 335 46 42 Foreign 502 228 71 Total current 6,547 1,977 595 Deferred income taxes: Federal (2,499) (2,165) (420) State (206) — — Foreign 216 1 14 Total deferred (2,489) (2,164) (406) Income tax expense (benefit) $ 4,058 $ (187) $ 189 |
Schedule of Income Before Income Tax | Income before income tax consists of the following: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) U.S. $ 29,495 $ 3,477 $ 8,446 Foreign 4,323 704 1,495 Income before income tax $ 33,818 $ 4,181 $ 9,941 |
Schedule of Effective Income Tax Rate Reconciliation | The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income before income taxes as follows: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions, except percentages) Tax expense computed at federal statutory rate $ 7,102 21.0 % $ 878 21.0 % $ 2,088 21.0 % Expense (benefit) resulting from: State income taxes, net of federal tax effect 120 0.4 % 50 1.2 % 42 0.4 % Foreign-derived intangible income (1,408) (4.2) % (739) (17.7) % (520) (5.2) % Stock-based compensation (741) (2.2) % (309) (7.4) % (337) (3.4) % Foreign tax rate differential (467) (1.4) % (83) (2.0) % (497) (5.0) % U.S. federal research and development tax credit (431) (1.3) % (278) (6.6) % (289) (2.9) % Acquisition termination cost — — % 261 6.2 % — — % IP domestication — — % — — % (244) (2.5) % Other (117) (0.3) % 33 0.8 % (54) (0.5) % Income tax expense (benefit) $ 4,058 12.0 % $ (187) (4.5) % $ 189 1.9 % |
Schedule of Deferred Tax Assets and Liabilities | The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below: Jan 28, 2024 Jan 29, 2023 (In millions) Deferred tax assets: Capitalized research and development expenditure $ 3,376 $ 1,859 GILTI deferred tax assets 1,576 800 Accruals and reserves, not currently deductible for tax purposes 1,121 686 Research and other tax credit carryforwards 936 951 Net operating loss and capital loss carryforwards 439 409 Operating lease liabilities 263 193 Stock-based compensation 106 99 Property, equipment and intangible assets 4 66 Other deferred tax assets 179 91 Gross deferred tax assets 8,000 5,154 Less valuation allowance (1,552) (1,484) Total deferred tax assets 6,448 3,670 Deferred tax liabilities: Unremitted earnings of foreign subsidiaries (502) (228) Operating lease assets (255) (179) Acquired intangibles (74) (115) Gross deferred tax liabilities (831) (522) Net deferred tax asset (1) $ 5,617 $ 3,148 (1) Net deferred tax asset includes long-term deferred tax assets of $6.1 billion and $3.4 billion and long-term deferred tax liabilities of $462 million and $247 million for fiscal years 2024 and 2023, respectively. Long-term deferred tax liabilities are included in other long-term liabilities on our Consolidated Balance Sheets. |
Schedule of Gross Unrecognized Tax Benefits | A reconciliation of gross unrecognized tax benefits is as follows: Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) Balance at beginning of period $ 1,238 $ 1,013 $ 776 Increases in tax positions for current year 616 268 246 Increases in tax positions for prior years 87 1 14 Decreases in tax positions for prior years (148) (15) (4) Settlements (104) (9) (8) Lapse in statute of limitations (19) (20) (11) Balance at end of period $ 1,670 $ 1,238 $ 1,013 |
Segment Information (Tables)
Segment Information (Tables) | 12 Months Ended |
Jan. 28, 2024 | |
Segment Reporting [Abstract] | |
Schedule of Reportable Segments | Compute & Networking Graphics All Other Consolidated (In millions) Year Ended Jan 28, 2024: Revenue $ 47,405 $ 13,517 $ — $ 60,922 Operating income (loss) $ 32,016 $ 5,846 $ (4,890) $ 32,972 Year Ended Jan 29, 2023: Revenue $ 15,068 $ 11,906 $ — $ 26,974 Operating income (loss) $ 5,083 $ 4,552 $ (5,411) $ 4,224 Year Ended Jan 30, 2022: Revenue $ 11,046 $ 15,868 $ — $ 26,914 Operating income (loss) $ 4,598 $ 8,492 $ (3,049) $ 10,041 Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 (In millions) Reconciling items included in "All Other" category: Stock-based compensation expense $ (3,549) $ (2,710) $ (2,004) Unallocated cost of revenue and operating expenses (728) (595) (399) Acquisition-related and other costs (583) (674) (636) IP-related and legal settlement costs (40) (23) (10) Restructuring costs and other — (54) — Acquisition termination cost — (1,353) — Other 10 (2) — Total $ (4,890) $ (5,411) $ (3,049) |
Schedule of Revenue by Geographic Regions | : Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 Revenue: (In millions) United States $ 26,966 $ 8,292 $ 4,349 Taiwan 13,405 6,986 8,544 China (including Hong Kong) 10,306 5,785 7,111 Other countries 10,245 5,911 6,910 Total revenue $ 60,922 $ 26,974 $ 26,914 |
Schedule of Revenue by Specialized Markets | The following table summarizes information pertaining to our revenue by each of the specialized markets we serve: Year Ended Jan 28, 2024 Jan 29, 2023 Jan 30, 2022 Revenue: (In millions) Data Center $ 47,525 $ 15,005 $ 10,613 Gaming 10,447 9,067 12,462 Professional Visualization 1,553 1,544 2,111 Automotive 1,091 903 566 OEM and Other 306 455 1,162 Total revenue $ 60,922 $ 26,974 $ 26,914 |
Schedule of Long-Lived Assets by Geographic Region | The following table presents summarized information for long-lived assets by country. Long-lived assets consist of property and equipment and exclude other assets, operating lease assets, goodwill, and intangible assets. Jan 28, 2024 Jan 29, 2023 Long-lived assets: (In millions) United States $ 2,595 $ 2,587 Taiwan 773 702 Israel 325 283 Other countries 221 235 Total long-lived assets $ 3,914 $ 3,807 |
Organization and Summary of S_3
Organization and Summary of Significant Accounting Policies (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | 12 Months Ended | ||||
Jan. 28, 2024 | Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | Feb. 28, 2023 | Jan. 31, 2023 | |
Property, Plant and Equipment [Line Items] | ||||||
Cost of revenue benefit | $ (16,621) | $ (11,618) | $ (9,439) | |||
Operating expense benefit | (11,329) | (11,132) | (7,434) | |||
Net income | $ 29,760 | $ 4,368 | $ 9,752 | |||
Basic (in USD per share) | $ 12.05 | $ 1.76 | $ 3.91 | |||
Diluted (in USD per share) | $ 11.93 | $ 1.74 | $ 3.85 | |||
Operating income (loss) | $ 32,972 | $ 4,224 | $ 10,041 | |||
Valuation allowance | $ 1,552 | $ 1,552 | $ 1,484 | |||
Service Life | ||||||
Property, Plant and Equipment [Line Items] | ||||||
Cost of revenue benefit | 33 | |||||
Operating expense benefit | 102 | |||||
Net income | $ 114 | |||||
Basic (in USD per share) | $ 0.05 | |||||
Diluted (in USD per share) | $ 0.05 | |||||
Operating income (loss) | $ 135 | |||||
Server, Storage and Net work Equipment | ||||||
Property, Plant and Equipment [Line Items] | ||||||
Property, plant & equipment, useful life | 3 years | |||||
Buildings | ||||||
Property, Plant and Equipment [Line Items] | ||||||
Property, plant & equipment, useful life | 30 years | 30 years | ||||
Minimum | ||||||
Property, Plant and Equipment [Line Items] | ||||||
Property, plant & equipment, useful life | 3 years | 3 years | ||||
Warranty liability, term | 1 year | |||||
Intangible assets, useful life | 1 year | 1 year | ||||
Minimum | Server, Storage and Net work Equipment | ||||||
Property, Plant and Equipment [Line Items] | ||||||
Property, plant & equipment, useful life | 4 years | |||||
Minimum | Assembling and Testing Equipment | ||||||
Property, Plant and Equipment [Line Items] | ||||||
Property, plant & equipment, useful life | 5 years | |||||
Maximum | ||||||
Property, Plant and Equipment [Line Items] | ||||||
Property, plant & equipment, useful life | 7 years | 7 years | ||||
Warranty liability, term | 3 years | |||||
Intangible assets, useful life | 20 years | 20 years | ||||
Maximum | Server, Storage and Net work Equipment | ||||||
Property, Plant and Equipment [Line Items] | ||||||
Property, plant & equipment, useful life | 5 years | |||||
Maximum | Assembling and Testing Equipment | ||||||
Property, Plant and Equipment [Line Items] | ||||||
Property, plant & equipment, useful life | 7 years |
Business Combination (Details)
Business Combination (Details) $ in Billions | 12 Months Ended |
Jan. 29, 2023 USD ($) | |
Arm Limited | |
Business Acquisition [Line Items] | |
Transaction costs | $ 1.4 |
Leases - Schedule of Future Min
Leases - Schedule of Future Minimum Lease Payments (Details) - USD ($) $ in Millions | Jan. 28, 2024 | Jan. 29, 2023 |
Leases [Abstract] | ||
2025 | $ 290 | |
2026 | 270 | |
2027 | 253 | |
2028 | 236 | |
2029 | 202 | |
2030 and thereafter | 288 | |
Total | 1,539 | |
Less imputed interest | 192 | |
Present value of net future minimum lease payments | $ 1,347 | |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] | Accrued and other current liabilities | Accrued and other current liabilities |
Less short-term operating lease liabilities | $ 228 | $ 176 |
Long-term operating lease liabilities | $ 1,119 | $ 902 |
Leases - Narrative (Details)
Leases - Narrative (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Lessee, Lease, Description [Line Items] | |||
Lease not yet commenced, undiscounted amount | $ 1,100 | ||
Operating lease expense | $ 269 | $ 193 | $ 168 |
Weighted average remaining lease term - operating leases | 6 years 1 month 6 days | 6 years 9 months 18 days | |
Weighted average discount rate - operating leases | 3.76% | 3.21% | |
Minimum | |||
Lessee, Lease, Description [Line Items] | |||
Lease not yet commenced, term of contract | 1 year | ||
Maximum | |||
Lessee, Lease, Description [Line Items] | |||
Lease not yet commenced, term of contract | 10 years |
Leases - Schedule of other leas
Leases - Schedule of other lease information (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Leases [Abstract] | |||
Operating cash flows used for operating leases | $ 286 | $ 184 | $ 154 |
Operating lease assets obtained in exchange for lease obligations | $ 531 | $ 358 | $ 266 |
Stock-Based Compensation - Sche
Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Stock-based compensation expense | $ 3,549 | $ 2,710 | $ 2,004 |
Cost of revenue | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Stock-based compensation expense | 141 | 138 | 141 |
Research and development | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Stock-based compensation expense | 2,532 | 1,892 | 1,298 |
Sales, general and administrative | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Stock-based compensation expense | $ 876 | $ 680 | $ 565 |
Stock-Based Compensation - Summ
Stock-Based Compensation - Summary of Equity Awards (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Awards granted (in shares) | 14 | ||
Weighted average grant date fair value (in dollars per share) | $ 374.08 | ||
Summary of unearned SBC expense | |||
Unearned stock-based compensation expense | $ 8,600 | ||
RSUs, PSUs and Market-based PSUs | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Awards granted (in shares) | 14 | 25 | 18 |
Estimated total grant-date fair value | $ 5,316 | $ 4,505 | $ 3,492 |
Weighted average grant date fair value (in dollars per share) | $ 374.08 | $ 183.72 | $ 190.69 |
Summary of unearned SBC expense | |||
Estimated weighted average amortization period | 2 years 6 months | ||
Employee Stock Purchase Plan | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Awards granted (in shares) | 3 | 3 | 5 |
Weighted average price (in dollars per share) | $ 158.07 | $ 122.54 | $ 56.36 |
Weighted average grant date fair value (in dollars per share) | $ 69.90 | $ 51.87 | $ 23.24 |
Summary of unearned SBC expense | |||
Estimated weighted average amortization period | 9 months 18 days | ||
Fair Value Assumptions | |||
Risk free interest rate, minimum | 3.90% | 0% | 0% |
Risk free interest rate, maximum | 5.50% | 4.60% | 0.50% |
Volatility rate, minimum | 31% | 43% | 20% |
Volatility rate, maximum | 67% | 72% | 58% |
Dividend yield | 10% | 0.10% | |
Employee Stock Purchase Plan | Minimum | |||
Fair Value Assumptions | |||
Weighted average expected life (in years) | 1 month 6 days | 1 month 6 days | 1 month 6 days |
Dividend yield | 0.10% | ||
Employee Stock Purchase Plan | Maximum | |||
Fair Value Assumptions | |||
Weighted average expected life (in years) | 2 years | 2 years | 2 years |
Stock-Based Compensation - Narr
Stock-Based Compensation - Narrative (Details) shares in Millions, $ in Billions | 12 Months Ended | ||
Jan. 28, 2024 USD ($) period shares | Jan. 29, 2023 USD ($) shares | Jan. 30, 2022 USD ($) | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Number of shares may be issued under the Restated 2007 Plan (in shares) | 37 | ||
Number of shares available for grant (in shares) | 147 | 160 | |
Employee stock purchase plan, offering period duration | 24 months | ||
Employee stock purchase plan, number of purchase periods in offering period | period | 4 | ||
Employee stock purchase plan, purchase period duration | 6 months | ||
RSUs, PSUs and Market-based PSUs | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Number of shares available for grant (in shares) | 147 | ||
Total fair value of units as of respective vesting dates | $ | $ 8.2 | $ 4.3 | $ 5.6 |
Restricted Stock Units (RSUs) | Tranche One | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Award vesting period | 4 years | ||
Vesting rights (as percent) | 25% | ||
Quarterly vesting schedule - RSUs and PSUs (as percent) | 6.25% | ||
Restricted Stock Units (RSUs) | Tranche Two | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Award vesting period | 3 years | ||
Vesting rights (as percent) | 40% | ||
Quarterly vesting schedule - RSUs and PSUs (as percent) | 7.50% | ||
Restricted Stock Units (RSUs) | Tranche Three | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Award vesting period | 4 years | ||
Quarterly vesting schedule - RSUs and PSUs (as percent) | 6.25% | ||
Performance Stock Units | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Award vesting period | 4 years | ||
Vesting rights (as percent) | 25% | ||
Quarterly vesting schedule - RSUs and PSUs (as percent) | 6.25% | ||
Market-based PSUs | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Award vesting period | 3 years | ||
Vesting rights (as percent) | 100% | ||
Employee Stock Purchase Plan | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Maximum employee subscription rate (as percent) | 15% | ||
Purchase price of ESPP (as percent) | 85% | ||
Shares reserved for future issuance (in shares) | 227 |
Stock-Based Compensation - Equi
Stock-Based Compensation - Equity Incentive Plans (Details) shares in Millions | 12 Months Ended |
Jan. 28, 2024 $ / shares shares | |
Number of Shares | |
RSUs, PSUs and Market-based PSUs, outstanding, beginning balance (in shares) | shares | 45 |
RSUs, PSUs and Market-based PSUs, granted (in shares) | shares | 14 |
RSUs, PSUs and Market-based PSUs, vested (in shares) | shares | (21) |
RSUs, PSUs and Market-based PSUs, canceled and forfeited (in shares) | shares | (1) |
RSUs, PSUs and Market-based PSUs, outstanding, ending balance (in shares) | shares | 37 |
Vested and expected to vest, RSUs, PSUs and Market-based PSUs (in shares) | shares | 37 |
Weighted Average Grant-Date Fair Value | |
PSUs and Market-based PSUs, weighted average grant date fair value, beginning balance (in USD per share) | $ / shares | $ 158.45 |
PSUs and Market-based PSUs, weighted average grant date fair value, granted (in USD per share) | $ / shares | 374.08 |
PSUs and Market-based PSUs, weighted average grant date fair value, vested (in USD per share) | $ / shares | 148.56 |
PSUs and Market-based PSUs, weighted average grant date fair value, canceled and forfeited (in USD per share) | $ / shares | 206.35 |
PSUs and Market-based PSUs, weighted average grant date fair value, ending balance (in USD per share) | $ / shares | 245.94 |
Vested and expected to vest, RSUs, PSUs and Market-based PSUs, weighted average grant date fair value (in USD per share) | $ / shares | $ 245.49 |
Net Income Per Share (Details)
Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Numerator: | |||
Net income | $ 29,760 | $ 4,368 | $ 9,752 |
Denominator: | |||
Basic weighted average shares (in shares) | 2,469 | 2,487 | 2,496 |
Dilutive impact of outstanding equity awards (in shares) | 25 | 20 | 39 |
Diluted weighted average shares (in shares) | 2,494 | 2,507 | 2,535 |
Net income per share: | |||
Basic (in USD per share) | $ 12.05 | $ 1.76 | $ 3.91 |
Diluted (in USD per share) | $ 11.93 | $ 1.74 | $ 3.85 |
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive (in shares) | 15 | 40 | 21 |
Goodwill (Details)
Goodwill (Details) - USD ($) | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Goodwill [Line Items] | |||
Goodwill | $ 4,430,000,000 | $ 4,372,000,000 | |
Goodwill acquired during period | 59,000,000 | ||
Goodwill impairment loss | 0 | 0 | $ 0 |
Compute & Networking | |||
Goodwill [Line Items] | |||
Goodwill | 4,100,000,000 | 4,000,000,000 | |
Graphics | |||
Goodwill [Line Items] | |||
Goodwill | $ 370,000,000 | $ 370,000,000 |
Amortizable Intangible Assets_2
Amortizable Intangible Assets (Details) - USD ($) $ in Millions | 12 Months Ended | |||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | May 01, 2022 | |
Finite-Lived Intangible Assets [Line Items] | ||||
Gross Carrying Amount | $ 3,091 | $ 3,539 | ||
Accumulated Amortization | (1,979) | (1,863) | ||
Net Carrying Amount | 1,112 | 1,676 | ||
Amortization expense | 614 | 699 | $ 563 | |
Future amortization expense associated with intangible assets | ||||
Fiscal 2025 | 555 | |||
Fiscal 2026 | 261 | |||
Fiscal 2027 | 150 | |||
Fiscal 2028 | 37 | |||
Fiscal 2029 | 9 | |||
Fiscal 2030 and thereafter | 100 | |||
Net Carrying Amount | 1,112 | 1,676 | ||
Acquisition-related intangible assets | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Gross Carrying Amount | 2,642 | 3,093 | ||
Accumulated Amortization | (1,720) | (1,614) | ||
Net Carrying Amount | 922 | 1,479 | ||
Future amortization expense associated with intangible assets | ||||
Net Carrying Amount | 922 | 1,479 | ||
Patents and licensed technology | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Gross Carrying Amount | 449 | 446 | ||
Accumulated Amortization | (259) | (249) | ||
Net Carrying Amount | 190 | 197 | ||
Future amortization expense associated with intangible assets | ||||
Net Carrying Amount | $ 190 | $ 197 | ||
In process research and development | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Gross Carrying Amount | $ 630 |
Cash Equivalents and Marketab_3
Cash Equivalents and Marketable Securities - Cash Equivalents and Marketable Securities (Details) - USD ($) $ in Millions | Jan. 28, 2024 | Jan. 29, 2023 |
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 25,684 | $ 13,112 |
Unrealized Gain | 56 | 1 |
Unrealized Loss | (16) | (58) |
Estimated Fair Value | 25,724 | 13,055 |
Cash Equivalents | 7,020 | 3,148 |
Marketable Securities | 18,704 | 9,907 |
Corporate debt securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 10,126 | 4,809 |
Unrealized Gain | 31 | 0 |
Unrealized Loss | (5) | (12) |
Estimated Fair Value | 10,152 | 4,797 |
Cash Equivalents | 2,231 | 1,087 |
Marketable Securities | 7,921 | 3,710 |
Debt securities issued by the U.S. Treasury | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 9,517 | 4,185 |
Unrealized Gain | 17 | 1 |
Unrealized Loss | (10) | (44) |
Estimated Fair Value | 9,524 | 4,142 |
Cash Equivalents | 1,315 | 0 |
Marketable Securities | 8,209 | 4,142 |
Debt securities issued by U.S. government agencies | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 2,326 | 1,836 |
Unrealized Gain | 8 | 0 |
Unrealized Loss | (1) | (2) |
Estimated Fair Value | 2,333 | 1,834 |
Cash Equivalents | 89 | 50 |
Marketable Securities | 2,244 | 1,784 |
Money market funds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 3,031 | 1,777 |
Unrealized Gain | 0 | 0 |
Unrealized Loss | 0 | 0 |
Estimated Fair Value | 3,031 | 1,777 |
Cash Equivalents | 3,031 | 1,777 |
Marketable Securities | 0 | 0 |
Certificates of deposit | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 510 | 365 |
Unrealized Gain | 0 | 0 |
Unrealized Loss | 0 | 0 |
Estimated Fair Value | 510 | 365 |
Cash Equivalents | 294 | 134 |
Marketable Securities | 216 | 231 |
Foreign government bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 174 | 140 |
Unrealized Gain | 0 | 0 |
Unrealized Loss | 0 | 0 |
Estimated Fair Value | 174 | 140 |
Cash Equivalents | 60 | 100 |
Marketable Securities | $ 114 | $ 40 |
Cash Equivalents and Marketab_4
Cash Equivalents and Marketable Securities - Unrealized Losses Aggregated by Investment Category (Details) - USD ($) $ in Millions | Jan. 28, 2024 | Jan. 29, 2023 |
Estimated Fair Value | ||
Less than 12 Months | $ 5,319 | $ 4,939 |
12 Months or Greater | 1,696 | 1,868 |
Total | 7,015 | 6,807 |
Gross Unrealized Loss | ||
Less than 12 Months | (9) | (30) |
12 Months or Greater | (7) | (28) |
Total | (16) | (58) |
Debt securities issued by the U.S. Treasury | ||
Estimated Fair Value | ||
Less than 12 Months | 3,343 | 2,444 |
12 Months or Greater | 1,078 | 1,172 |
Total | 4,421 | 3,616 |
Gross Unrealized Loss | ||
Less than 12 Months | (5) | (21) |
12 Months or Greater | (5) | (23) |
Total | (10) | (44) |
Corporate debt securities | ||
Estimated Fair Value | ||
Less than 12 Months | 1,306 | 1,188 |
12 Months or Greater | 618 | 696 |
Total | 1,924 | 1,884 |
Gross Unrealized Loss | ||
Less than 12 Months | (3) | (7) |
12 Months or Greater | (2) | (5) |
Total | (5) | (12) |
Debt securities issued by U.S. government agencies | ||
Estimated Fair Value | ||
Less than 12 Months | 670 | 1,307 |
12 Months or Greater | 0 | 0 |
Total | 670 | 1,307 |
Gross Unrealized Loss | ||
Less than 12 Months | (1) | (2) |
12 Months or Greater | 0 | 0 |
Total | $ (1) | $ (2) |
Cash Equivalents and Marketab_5
Cash Equivalents and Marketable Securities - Amortized Cost and Estimated Fair Value of Cash Equivalents and Marketable Securities (Details) - USD ($) $ in Millions | Jan. 28, 2024 | Jan. 29, 2023 |
Amortized Cost | ||
Less than one year | $ 16,336 | $ 9,738 |
Due in 1 - 5 years | 9,348 | 3,374 |
Amortized Cost | 25,684 | 13,112 |
Estimated Fair Value | ||
Less than one year | 16,329 | 9,708 |
Due in 1 - 5 years | 9,395 | 3,347 |
Estimated Fair Value | $ 25,724 | $ 13,055 |
Fair Value of Financial Asset_3
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities (Details) - USD ($) $ in Millions | Jan. 28, 2024 | Jan. 29, 2023 |
Assets | ||
Cash equivalents and marketable securities | $ 25,724 | $ 13,055 |
Investments in non-affiliated entities | $ 1,546 | 299 |
0.309% Notes Due 2023 | ||
Financial assets and liabilities measured at fair value | ||
Interest rate (as percent) | 0.309% | |
0.584% Notes Due 2024 | ||
Financial assets and liabilities measured at fair value | ||
Interest rate (as percent) | 0.584% | |
3.20% Notes Due 2026 | ||
Financial assets and liabilities measured at fair value | ||
Interest rate (as percent) | 3.20% | |
1.55% Notes Due 2028 | ||
Financial assets and liabilities measured at fair value | ||
Interest rate (as percent) | 1.55% | |
2.85% Notes Due 2030 | ||
Financial assets and liabilities measured at fair value | ||
Interest rate (as percent) | 2.85% | |
2.00% Notes Due 2031 | ||
Financial assets and liabilities measured at fair value | ||
Interest rate (as percent) | 2% | |
3.50% Notes Due 2040 | ||
Financial assets and liabilities measured at fair value | ||
Interest rate (as percent) | 3.50% | |
3.50% Notes Due 2050 | ||
Financial assets and liabilities measured at fair value | ||
Interest rate (as percent) | 3.50% | |
3.70% Notes Due 2060 | ||
Financial assets and liabilities measured at fair value | ||
Interest rate (as percent) | 3.70% | |
Level 1 | Money market funds | ||
Assets | ||
Cash equivalents and marketable securities | $ 3,031 | 1,777 |
Level 1 | Publicly-held equity securities | ||
Assets | ||
Investments in non-affiliated entities | 225 | 11 |
Level 2 | 0.309% Notes Due 2023 | ||
Liabilities | ||
Long-term debt | 0 | 1,230 |
Level 2 | 0.584% Notes Due 2024 | ||
Liabilities | ||
Long-term debt | 1,228 | 1,185 |
Level 2 | 3.20% Notes Due 2026 | ||
Liabilities | ||
Long-term debt | 970 | 966 |
Level 2 | 1.55% Notes Due 2028 | ||
Liabilities | ||
Long-term debt | 1,115 | 1,099 |
Level 2 | 2.85% Notes Due 2030 | ||
Liabilities | ||
Long-term debt | 1,367 | 1,364 |
Level 2 | 2.00% Notes Due 2031 | ||
Liabilities | ||
Long-term debt | 1,057 | 1,044 |
Level 2 | 3.50% Notes Due 2040 | ||
Liabilities | ||
Long-term debt | 851 | 870 |
Level 2 | 3.50% Notes Due 2050 | ||
Liabilities | ||
Long-term debt | 1,604 | 1,637 |
Level 2 | 3.70% Notes Due 2060 | ||
Liabilities | ||
Long-term debt | 403 | 410 |
Level 2 | Corporate debt securities | ||
Assets | ||
Cash equivalents and marketable securities | 10,152 | 4,797 |
Level 2 | Debt securities issued by the U.S. Treasury | ||
Assets | ||
Cash equivalents and marketable securities | 9,524 | 4,142 |
Level 2 | Debt securities issued by U.S. government agencies | ||
Assets | ||
Cash equivalents and marketable securities | 2,333 | 1,834 |
Level 2 | Certificates of deposit | ||
Assets | ||
Cash equivalents and marketable securities | 510 | 365 |
Level 2 | Foreign government bonds | ||
Assets | ||
Cash equivalents and marketable securities | $ 174 | $ 140 |
Fair Value of Financial Asset_4
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | |
Jan. 28, 2024 | Jan. 29, 2023 | |
Financial assets and liabilities measured at fair value | ||
Investments in non-affiliated entities | $ 1,546 | $ 299 |
Unrealized gains | 178 | |
Adjustment, cumulative amount | 174 | |
Publicly-held equity securities | Level 1 | ||
Financial assets and liabilities measured at fair value | ||
Investments in non-affiliated entities | 225 | 11 |
Privately-held equity securities | Level 3 | ||
Financial assets and liabilities measured at fair value | ||
Investments in non-affiliated entities | $ 1,300 | $ 288 |
Fair Value of Financial Asset_5
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities - Carrying Value of Non-marketable Equity Securities (Details) $ in Millions | 12 Months Ended |
Jan. 28, 2024 USD ($) | |
Investments, Debt and Equity Securities [Abstract] | |
Carrying amount, beginning | $ 288 |
Net additions | 859 |
Unrealized gains | 194 |
Impairments and unrealized losses | (20) |
Carrying amount, ending | $ 1,321 |
Fair Value of Financial Asset_6
Fair Value of Financial Assets and Liabilities and Investments in Non-Affiliated Entities - Cumulative Gross (Details) $ in Millions | Jan. 28, 2024 USD ($) |
Investments, Debt and Equity Securities [Abstract] | |
Adjustment, cumulative amount | $ 270 |
Cumulative gross unrealized losses and impairments | $ (45) |
Balance Sheet Components - Inve
Balance Sheet Components - Inventories (Details) - USD ($) $ in Millions | 12 Months Ended | |
Jan. 28, 2024 | Jan. 29, 2023 | |
Inventories | ||
Raw materials | $ 1,719 | $ 2,430 |
Work in-process | 1,505 | 466 |
Finished goods | 2,058 | 2,263 |
Total inventories | 5,282 | 5,159 |
Inventory reserves expenses | $ 774 | $ 1,000 |
Balance Sheet Components - Prop
Balance Sheet Components - Property and Equipment (Details) - USD ($) $ in Millions | Jan. 28, 2024 | Jan. 29, 2023 |
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, gross | $ 7,423 | $ 6,501 |
Accumulated depreciation and amortization | (3,509) | (2,694) |
Total property and equipment, net | $ 3,914 | 3,807 |
Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Property, plant & equipment, useful life | 3 years | |
Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Property, plant & equipment, useful life | 7 years | |
Land | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, gross | $ 218 | 218 |
Buildings, leasehold improvements, and furniture | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, gross | 1,816 | 1,598 |
Equipment, compute hardware, and software | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, gross | $ 5,200 | 4,303 |
Equipment, compute hardware, and software | Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Property, plant & equipment, useful life | 3 years | |
Equipment, compute hardware, and software | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Property, plant & equipment, useful life | 7 years | |
Construction in process | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment, gross | $ 189 | $ 382 |
Buildings | ||
Property, Plant and Equipment [Line Items] | ||
Property, plant & equipment, useful life | 30 years |
Balance Sheet Components - Narr
Balance Sheet Components - Narrative (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Property, Plant and Equipment [Line Items] | |||
Depreciation expense | $ 894 | $ 844 | $ 611 |
Accumulated amortization of lease hold improvements and capital lease | 400 | 327 | |
Capital expenditures incurred but not yet paid | 170 | 374 | $ 258 |
Deferred revenue | $ 338 | $ 282 | |
Significant Customer | Accounts Receivable | Customer Concentration Risk | |||
Property, Plant and Equipment [Line Items] | |||
Concentration risk (as percent) | 24% | 14% | |
Two Customers | Accounts Receivable | Customer Concentration Risk | |||
Property, Plant and Equipment [Line Items] | |||
Concentration risk (as percent) | 11% | 11% |
Balance Sheet Components - Othe
Balance Sheet Components - Other Assets (Details) - USD ($) $ in Millions | Jan. 28, 2024 | Jan. 29, 2023 |
Supply Commitment [Line Items] | ||
Prepaid supply and capacity agreements | $ 2,458 | $ 2,989 |
Investments in non-affiliated entities | 1,546 | 299 |
Prepaid royalties | 364 | 387 |
Other | 132 | 145 |
Other assets | 4,500 | 3,820 |
Prepaid expenses and other current assets | 3,080 | 791 |
Supply and Capacity Agreements | ||
Supply Commitment [Line Items] | ||
Prepaid expenses and other current assets | $ 2,500 | $ 458 |
Balance Sheet Components - Accr
Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Accrued and Other Current Liabilities: | |||
Customer program accruals | $ 2,081 | $ 1,196 | |
Excess inventory purchase obligations | 1,655 | 954 | |
Deferred revenue | 764 | 354 | |
Accrued payroll and related expenses | 675 | 530 | |
Product warranty and return provisions | 415 | 108 | |
Taxes payable | $ 296 | $ 467 | |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] | Accrued and other current liabilities | Accrued and other current liabilities | |
Operating leases | $ 228 | $ 176 | |
Unsettled share repurchases | 187 | 117 | |
Licenses and royalties | 182 | 149 | |
Other | 199 | 69 | |
Accrued and other current liabilities | 6,682 | 4,120 | |
Cost of revenue | 16,621 | 11,618 | $ 9,439 |
Inventory purchase obligations in excess of projections | |||
Accrued and Other Current Liabilities: | |||
Cost of revenue | 1,400 | 1,100 | |
Customer advances | |||
Accrued and Other Current Liabilities: | |||
Deferred revenue | $ 233 | $ 35 |
Balance Sheet Components - Ot_2
Balance Sheet Components - Other Long-Term Liabilities (Details) - USD ($) $ in Millions | Jan. 28, 2024 | Jan. 29, 2023 |
Other Long-Term Liabilities: | ||
Income tax payable | $ 1,361 | $ 1,204 |
Deferred income tax | 462 | 247 |
Deferred revenue | 573 | 218 |
Licenses payable | 80 | 181 |
Other | 65 | 63 |
Total other long-term liabilities | $ 2,541 | $ 1,913 |
Balance Sheet Components - Defe
Balance Sheet Components - Deferred Revenue (Details) - USD ($) $ in Millions | 12 Months Ended | |
Jan. 28, 2024 | Jan. 29, 2023 | |
Movement in Deferred Revenue [Roll Forward] | ||
Balance at beginning of period | $ 572 | $ 502 |
Deferred revenue additions during the period | 2,038 | 830 |
Revenue recognized during the period | (1,273) | (760) |
Balance at end of period | $ 1,337 | $ 572 |
Balance Sheet Components - Reve
Balance Sheet Components - Revenue Remaining Performance Obligation (Details) $ in Billions | Jan. 28, 2024 USD ($) |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligation | $ 1.1 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-29 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligation (as percent) | 40% |
Expected performance period | 12 months |
Derivative Financial Instrume_3
Derivative Financial Instruments - Notional Value of Our Foreign Currency Forward Contracts Outstanding (Details) - Foreign currency forward contract - USD ($) $ in Millions | Jan. 28, 2024 | Jan. 29, 2023 |
Designated as Hedging Instrument | ||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||
Notional values of derivative contracts | $ 1,168 | $ 1,128 |
Not Designated as Hedging Instrument | ||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||
Notional values of derivative contracts | $ 597 | $ 366 |
Derivative Financial Instrume_4
Derivative Financial Instruments - Narrative (Details) | 12 Months Ended |
Jan. 28, 2024 | |
Foreign currency forward contract | |
Derivative [Line Items] | |
Maximum maturity period | 18 months |
Debt - Narrative (Details)
Debt - Narrative (Details) - USD ($) | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Debt Instrument [Line Items] | |||
Proceeds from issuance of bet, net of issuance costs | $ 0 | $ 0 | $ 4,977,000,000 |
Repayment of debt | 1,250,000,000 | $ 0 | $ 1,000,000,000 |
Outstanding commercial paper | 0 | ||
Commercial Paper | |||
Debt Instrument [Line Items] | |||
Maximum borrowing capacity | $ 575,000,000 | ||
0.309% Notes Due 2023 | |||
Debt Instrument [Line Items] | |||
Stated interest rate (percent) | 0.309% |
Debt - Schedule of Debt (Detail
Debt - Schedule of Debt (Details) - USD ($) $ in Millions | 12 Months Ended | |
Jan. 28, 2024 | Jan. 29, 2023 | |
Debt Instrument [Line Items] | ||
Unamortized debt discount and issuance costs | $ (41) | $ (47) |
Net carrying amount | 9,709 | 10,953 |
Less short-term portion | (1,250) | (1,250) |
Long-term debt | $ 8,459 | 9,703 |
0.309% Notes Due 2023 | ||
Debt Instrument [Line Items] | ||
Interest rate (as percent) | 0.309% | |
Effective Interest Rate (as percent) | 0.41% | |
Gross carrying amount | $ 0 | 1,250 |
0.584% Notes Due 2024 | ||
Debt Instrument [Line Items] | ||
Interest rate (as percent) | 0.584% | |
Expected Remaining Term (years) | 4 months 24 days | |
Effective Interest Rate (as percent) | 0.66% | |
Gross carrying amount | $ 1,250 | 1,250 |
3.20% Notes Due 2026 | ||
Debt Instrument [Line Items] | ||
Interest rate (as percent) | 3.20% | |
Expected Remaining Term (years) | 2 years 7 months 6 days | |
Effective Interest Rate (as percent) | 3.31% | |
Gross carrying amount | $ 1,000 | 1,000 |
1.55% Notes Due 2028 | ||
Debt Instrument [Line Items] | ||
Interest rate (as percent) | 1.55% | |
Expected Remaining Term (years) | 4 years 4 months 24 days | |
Effective Interest Rate (as percent) | 1.64% | |
Gross carrying amount | $ 1,250 | 1,250 |
2.85% Notes Due 2030 | ||
Debt Instrument [Line Items] | ||
Interest rate (as percent) | 2.85% | |
Expected Remaining Term (years) | 6 years 2 months 12 days | |
Effective Interest Rate (as percent) | 2.93% | |
Gross carrying amount | $ 1,500 | 1,500 |
2.00% Notes Due 2031 | ||
Debt Instrument [Line Items] | ||
Interest rate (as percent) | 2% | |
Expected Remaining Term (years) | 7 years 4 months 24 days | |
Effective Interest Rate (as percent) | 2.09% | |
Gross carrying amount | $ 1,250 | 1,250 |
3.50% Notes Due 2040 | ||
Debt Instrument [Line Items] | ||
Interest rate (as percent) | 3.50% | |
Expected Remaining Term (years) | 16 years 2 months 12 days | |
Effective Interest Rate (as percent) | 3.54% | |
Gross carrying amount | $ 1,000 | 1,000 |
3.50% Notes Due 2050 | ||
Debt Instrument [Line Items] | ||
Interest rate (as percent) | 3.50% | |
Expected Remaining Term (years) | 26 years 2 months 12 days | |
Effective Interest Rate (as percent) | 3.54% | |
Gross carrying amount | $ 2,000 | 2,000 |
3.70% Notes Due 2060 | ||
Debt Instrument [Line Items] | ||
Interest rate (as percent) | 3.70% | |
Expected Remaining Term (years) | 36 years 2 months 12 days | |
Effective Interest Rate (as percent) | 3.73% | |
Gross carrying amount | $ 500 | $ 500 |
Commitments and Contingencies -
Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions | Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | Jan. 31, 2021 |
Supply Commitment [Line Items] | ||||
Inventory purchase and long-term supply agreements | $ 16,100 | |||
Other purchase obligations | 4,600 | |||
Warranty accrual | 306 | $ 82 | $ 46 | $ 22 |
License and Service | ||||
Supply Commitment [Line Items] | ||||
Other purchase obligations | $ 3,500 |
Commitments and Contingencies_2
Commitments and Contingencies - Summary of Future Commitments Due by Year (Details) $ in Millions | Jan. 28, 2024 USD ($) |
Fiscal Year: | |
2025 | $ 17,316 |
2026 | 1,143 |
2027 | 1,060 |
2028 | 770 |
2029 and thereafter | 418 |
Total | $ 20,707 |
Commitments and Contingencies_3
Commitments and Contingencies - Schedule of Product Warranty Liabilities (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] | |||
Beginning Balance | $ 82 | $ 46 | $ 22 |
Additions | 278 | 145 | 40 |
Utilization | (54) | (109) | (16) |
Ending Balance | $ 306 | $ 82 | $ 46 |
Income Taxes - Components of In
Income Taxes - Components of Income Tax Expense (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Current income taxes: | |||
Federal | $ 5,710 | $ 1,703 | $ 482 |
State | 335 | 46 | 42 |
Foreign | 502 | 228 | 71 |
Total current | 6,547 | 1,977 | 595 |
Deferred income taxes: | |||
Federal | (2,499) | (2,165) | (420) |
State | (206) | 0 | 0 |
Foreign | 216 | 1 | 14 |
Total deferred | (2,489) | (2,164) | (406) |
Income tax expense (benefit) | 4,058 | (187) | 189 |
Income before Income Taxes | |||
U.S. | 29,495 | 3,477 | 8,446 |
Foreign | 4,323 | 704 | 1,495 |
Income before income tax | $ 33,818 | $ 4,181 | $ 9,941 |
Income Taxes - Income Tax Recon
Income Taxes - Income Tax Reconciliation (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract] | |||
Tax expense computed at federal statutory rate | $ 7,102 | $ 878 | $ 2,088 |
State income taxes, net of federal tax effect | 120 | 50 | 42 |
Foreign-derived intangible income | (1,408) | (739) | (520) |
Stock-based compensation | (741) | (309) | (337) |
Foreign tax rate differential | (467) | (83) | (497) |
U.S. federal research and development tax credit | (431) | (278) | (289) |
Acquisition termination cost | 0 | 261 | 0 |
IP domestication | 0 | 0 | (244) |
Other | (117) | 33 | (54) |
Income tax expense (benefit) | $ 4,058 | $ (187) | $ 189 |
Effective Income Tax Rate Reconciliation, Percent [Abstract] | |||
Tax expense computed at federal statutory rate | 21% | 21% | 21% |
State income taxes, net of federal tax effect | 0.40% | 1.20% | 0.40% |
Foreign-derived intangible income | (4.20%) | (17.70%) | (5.20%) |
Stock-based compensation | (2.20%) | (7.40%) | (3.40%) |
Foreign tax rate differential | (1.40%) | (2.00%) | (5.00%) |
U.S. federal research and development tax credit | (1.30%) | (6.60%) | (2.90%) |
Acquisition termination cost | 0 | 0.062 | 0 |
IP domestication | 0 | 0 | (0.025) |
Other | (0.30%) | 0.80% | (0.50%) |
Effective tax rate (as percent) | 12% | (4.50%) | 1.90% |
Income Taxes - Deferred Taxes (
Income Taxes - Deferred Taxes (Details) - USD ($) $ in Millions | Jan. 28, 2024 | Jan. 29, 2023 |
Deferred tax assets: | ||
Capitalized research and development expenditure | $ 3,376 | $ 1,859 |
GILTI deferred tax assets | 1,576 | 800 |
Accruals and reserves, not currently deductible for tax purposes | 1,121 | 686 |
Research and other tax credit carryforwards | 936 | 951 |
Net operating loss and capital loss carryforwards | 439 | 409 |
Operating lease liabilities | 263 | 193 |
Stock-based compensation | 106 | 99 |
Property, equipment and intangible assets | 4 | 66 |
Other deferred tax assets | 179 | 91 |
Gross deferred tax assets | 8,000 | 5,154 |
Less valuation allowance | (1,552) | (1,484) |
Total deferred tax assets | 6,448 | 3,670 |
Deferred tax liabilities: | ||
Unremitted earnings of foreign subsidiaries | (502) | (228) |
Operating lease assets | (255) | (179) |
Acquired intangibles | (74) | (115) |
Gross deferred tax liabilities | (831) | (522) |
Net deferred tax asset | 5,617 | 3,148 |
Deferred tax assets, noncurrent | ||
Deferred tax assets: | ||
Gross deferred tax assets | 6,100 | 3,400 |
Other long-term liabilities | ||
Deferred tax liabilities: | ||
Gross deferred tax liabilities | $ (462) | $ (247) |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Income Tax Contingency [Line Items] | |||
Valuation allowance | $ 1,552 | $ 1,484 | |
Deferred tax assets | 8,000 | 5,154 | |
Deferred tax liabilities | 831 | 522 | |
Unrecognized tax benefits that would affect effective tax rate | 1,000 | ||
Interest and taxes recognized related to unrecognized tax benefits | 42 | 33 | $ 14 |
Interest and penalties accrued | 140 | 95 | |
Other long-term liabilities | |||
Income Tax Contingency [Line Items] | |||
Deferred tax liabilities | 462 | 247 | |
Deferred tax assets, noncurrent | |||
Income Tax Contingency [Line Items] | |||
Deferred tax assets | 6,100 | $ 3,400 | |
Israel | Mellanox Technologies, Ltd | |||
Income Tax Contingency [Line Items] | |||
Undistributed earnings of foreign subsidiaries | 1,100 | ||
United Kingdom | Mellanox Technologies, Ltd | |||
Income Tax Contingency [Line Items] | |||
Undistributed earnings of foreign subsidiaries | 250 | ||
Federal | |||
Income Tax Contingency [Line Items] | |||
Net operating loss carryforwards | 315 | ||
Research tax credit carryforwards | 31 | ||
Federal | Capital Loss Carryforward | |||
Income Tax Contingency [Line Items] | |||
Federal capital loss carryforwards | 1,400 | ||
Foreign Country | |||
Income Tax Contingency [Line Items] | |||
Net operating loss carryforwards | 361 | ||
State and Local Jurisdiction | |||
Income Tax Contingency [Line Items] | |||
Net operating loss carryforwards | 342 | ||
Research tax credit carryforwards | 1,600 | ||
California | |||
Income Tax Contingency [Line Items] | |||
Research tax credit carryforwards | 1,500 | ||
Other states | |||
Income Tax Contingency [Line Items] | |||
Research tax credit carryforwards | $ 75 |
Income Taxes - Unrecognized Tax
Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Balance at beginning of period | $ 1,238 | $ 1,013 | $ 776 |
Increases in tax positions for current year | 616 | 268 | 246 |
Increases in tax positions for prior years | 87 | 1 | 14 |
Decreases in tax positions for prior years | (148) | (15) | (4) |
Settlements | (104) | (9) | (8) |
Lapse in statute of limitations | (19) | (20) | (11) |
Balance at end of period | 1,670 | $ 1,238 | $ 1,013 |
Unrecognized tax benefits that would affect effective tax rate | $ 1,000 |
Shareholders' Equity (Details)
Shareholders' Equity (Details) - USD ($) shares in Millions, $ in Millions | 1 Months Ended | 12 Months Ended | |||
Feb. 16, 2024 | Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | Aug. 31, 2023 | |
Equity, Class of Treasury Stock [Line Items] | |||||
Number of share repurchased (in shares) | 21 | ||||
Shares repurchased | $ 9,746 | $ 10,039 | |||
Additional number of shares authorized to be repurchased | $ 25,000 | ||||
Stock repurchase program, authorized amount | 22,500 | ||||
Dividends paid | 395 | 398 | $ 399 | ||
Retirement of treasury stock (in shares) | 349 | ||||
Retirement of treasury stock | $ 0 | ||||
Subsequent Event | |||||
Equity, Class of Treasury Stock [Line Items] | |||||
Number of share repurchased (in shares) | 2.8 | ||||
Shares repurchased | $ 1,900 | ||||
Additional Paid-in Capital | |||||
Equity, Class of Treasury Stock [Line Items] | |||||
Shares repurchased | 27 | 4 | |||
Retirement of treasury stock | 20 | ||||
Retained Earnings | |||||
Equity, Class of Treasury Stock [Line Items] | |||||
Shares repurchased | $ 9,719 | $ 10,034 | |||
Retirement of treasury stock | $ 12,026 |
Employee Retirement Plans (Deta
Employee Retirement Plans (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Retirement Benefits [Abstract] | |||
Defined contribution plan costs | $ 255 | $ 227 | $ 168 |
Segment Information - Narrative
Segment Information - Narrative (Details) - segment | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Segment Reporting Information [Line Items] | |||
Number of reportable segments | 2 | ||
Revenue | Customer Concentration Risk | Significant Customer | |||
Segment Reporting Information [Line Items] | |||
Concentration risk (as percent) | 13% | ||
Revenue | Customer Concentration Risk | Non-US | |||
Segment Reporting Information [Line Items] | |||
Concentration risk (as percent) | 56% | 69% | 84% |
Segment Information - Reportabl
Segment Information - Reportable Segments (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Segment Reporting Information [Line Items] | |||
Revenue | $ 60,922 | $ 26,974 | $ 26,914 |
Operating income (loss) | 32,972 | 4,224 | 10,041 |
All Other | |||
Segment Reporting Information [Line Items] | |||
Revenue | 0 | 0 | 0 |
Operating income (loss) | (4,890) | (5,411) | (3,049) |
Graphics | Operating segments | |||
Segment Reporting Information [Line Items] | |||
Revenue | 13,517 | 11,906 | 15,868 |
Operating income (loss) | 5,846 | 4,552 | 8,492 |
Compute & Networking | Operating segments | |||
Segment Reporting Information [Line Items] | |||
Revenue | 47,405 | 15,068 | 11,046 |
Operating income (loss) | $ 32,016 | $ 5,083 | $ 4,598 |
Segment Information - Reconcili
Segment Information - Reconciling Items (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Segment Reporting Information [Line Items] | |||
Stock-based compensation expense | $ (3,549) | $ (2,709) | $ (2,004) |
Operating income | 32,972 | 4,224 | 10,041 |
All Other | |||
Segment Reporting Information [Line Items] | |||
Stock-based compensation expense | (3,549) | (2,710) | (2,004) |
Unallocated cost of revenue and operating expenses | (728) | (595) | (399) |
Acquisition termination cost | 0 | (1,353) | 0 |
Acquisition-related and other costs | (583) | (674) | (636) |
IP-related and legal settlement costs | (40) | (23) | (10) |
Restructuring costs and other | 0 | (54) | 0 |
Other | 10 | (2) | 0 |
Operating income | $ (4,890) | $ (5,411) | $ (3,049) |
Segment Information - Revenue a
Segment Information - Revenue and Long-lived Assets by Region (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Revenues and Long-Lived Assets | |||
Revenue | $ 60,922 | $ 26,974 | $ 26,914 |
Long-lived assets | 3,914 | 3,807 | |
United States | |||
Revenues and Long-Lived Assets | |||
Revenue | 26,966 | 8,292 | 4,349 |
Long-lived assets | 2,595 | 2,587 | |
Taiwan | |||
Revenues and Long-Lived Assets | |||
Revenue | 13,405 | 6,986 | 8,544 |
Long-lived assets | 773 | 702 | |
China (including Hong Kong) | |||
Revenues and Long-Lived Assets | |||
Revenue | 10,306 | 5,785 | 7,111 |
Israel | |||
Revenues and Long-Lived Assets | |||
Long-lived assets | 325 | 283 | |
Other countries | |||
Revenues and Long-Lived Assets | |||
Revenue | 10,245 | 5,911 | $ 6,910 |
Long-lived assets | $ 221 | $ 235 |
Segment Information - Schedule
Segment Information - Schedule of Revenue by Market (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Revenue from External Customer [Line Items] | |||
Revenue | $ 60,922 | $ 26,974 | $ 26,914 |
Data Center | |||
Revenue from External Customer [Line Items] | |||
Revenue | 47,525 | 15,005 | 10,613 |
Gaming | |||
Revenue from External Customer [Line Items] | |||
Revenue | 10,447 | 9,067 | 12,462 |
Professional Visualization | |||
Revenue from External Customer [Line Items] | |||
Revenue | 1,553 | 1,544 | 2,111 |
Automotive | |||
Revenue from External Customer [Line Items] | |||
Revenue | 1,091 | 903 | 566 |
OEM and Other | |||
Revenue from External Customer [Line Items] | |||
Revenue | $ 306 | $ 455 | $ 1,162 |
Schedule II - Valuation and Q_2
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Jan. 28, 2024 | Jan. 29, 2023 | Jan. 30, 2022 | |
Allowance for doubtful accounts | |||
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Balance at Beginning of Period | $ 4 | $ 4 | $ 4 |
Additions | 0 | 0 | 0 |
Deductions | 0 | 0 | 0 |
Balance at End of Period | 4 | 4 | 4 |
Sales return allowance | |||
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Balance at Beginning of Period | 26 | 13 | 17 |
Additions | 213 | 104 | 19 |
Deductions | (130) | (91) | (23) |
Balance at End of Period | 109 | 26 | 13 |
Deferred tax valuation allowance | |||
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Balance at Beginning of Period | 1,484 | 907 | 728 |
Additions | 162 | 577 | 179 |
Deductions | (94) | 0 | 0 |
Balance at End of Period | $ 1,552 | $ 1,484 | $ 907 |